================================================================================

                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, WASHINGTON, D.C. 20549

FORM 10-Q

(Mark (Mark One)

[X]Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended:February 28, 2003
or          
[   ]Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from ___________________ to ___________________

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED: AUGUST 31, 2003 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 1-1520

GenCorp Inc.
(Exact name of registrant as specified in its charter)
Ohio
(State of Incorporation)
34-0244000
(I.R.S. Employer Identification No.)
Highway 50 and Aerojet Road
Rancho Cordova, California

(Address of Principal Executive Offices)
95670
(Zip Code)
P.O. Box 537012
Sacramento, California

(Mailing Address)
95853-7012
(Zip Code)

Registrant’s telephone number, including area code GENCORP INC. (Exact name of registrant as specified in its charter) OHIO 34-0244000 (State of Incorporation) (I.R.S. Employer Identification No.) HIGHWAY 50 AND AEROJET ROAD RANCHO CORDOVA, CALIFORNIA 95670 (Address of Principal Executive Offices) (Zip Code) P.O. BOX 537012 SACRAMENTO, CALIFORNIA 95853-7012 (Mailing Address) (Zip Code) REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE (916) 355-4000

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months, (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [x][X] No [ ]

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Act). Yes [x][X] No [ ]

As of March 21,September 30, 2003, there were 43,501,03943,989,168 outstanding shares of the Company’sCompany's Common Stock, $0.10 par value.




================================================================================ GENCORP INC. QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD ENDED AUGUST 31, 2003 TABLE OF CONTENTS

8-K................................ 43 SIGNATURES Signatures...................................................... 46
Part
ITEM NUMBER PAGE PART I - FINANCIAL INFORMATION
Item 1. 1 Financial Statements
Item 2. Management’sStatements............................................ 1 2 Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3.Operations........................................... 33 3 Quantitative and Qualitative Disclosures About Market Risk
Item 4.Risk...... 43 4 Controls and Procedures
Procedures......................................... 43 PART II - OTHER INFORMATION
Item 1. 1 Legal Proceedings
Item 4. Submission of Matters to a Vote of Security Holders
Item 6.Proceedings............................................... 43 6 Exhibits and Reports on Form 8-K
Signatures
CERTIFICATIONS
EX-10.1 Employee Restricted Stock Option Agrmnt


GenCorp Inc.

Quarterly Report on Form 10-Q
For the Quarterly Period Ended February 28, 2003

Table of Contents

     
Item    
Number   Page

   
  PART I – FINANCIAL INFORMATION  
     
1 Financial Statements   1
     
2 Management’s Discussion and Analysis of Financial Condition and Results of Operations 23
     
3 Quantitative and Qualitative Disclosures About Market Risk 29
     
4 Controls and Procedures 29
     
  PART II – OTHER INFORMATION  
     
1 Legal Proceedings 30
     
4 Submission of Matters to a Vote of Security Holders 30
     
6 Exhibits and Reports on Form 8-K 31
     
  SIGNATURES  
     
  Signatures 32


Part PART I - FINANCIAL INFORMATION

Item ITEM 1. Financial Statements

GenCorp Inc.

Condensed Consolidated Statements of Income
(Unaudited)

         
  Three months ended
  February 28,
  
  2003 2002
  
 
  (Dollars inmillions, except per share amounts)
   
Net Sales
 $271  $249 
Costs and Expenses
        
Cost of products sold  228   210 
Selling, general and administrative  18   14 
Depreciation and amortization  18   16 
Interest expense  5   3 
Other (income) expense, net  (3)  (1)
Unusual items    2 
   
   
 
Income Before Income Taxes
  5   5 
Provision for income taxes  2   2 
   
   
 
Net Income
 $3  $3 
   
   
 
Earnings Per Share of Common Stock
        
Basic $0.07  $0.07 
   
   
 
Diluted $0.07  $0.07 
   
   
 
Weighted average shares of common stock outstanding  43.0   42.7 
   
   
 
Weighted average shares of common stock outstanding, assuming dilution  43.1   43.1 
   
   
 
Dividends Declared Per Share of Common Stock
 $0.03  $0.03 
   
   
 

FINANCIAL STATEMENTS GENCORP INC. CONDENSED CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
THREE MONTHS ENDED NINE MONTHS ENDED AUGUST 31, AUGUST 31, ------------------- ------------------- 2003 2002 2002 2003 ------ ------ ------ ------ (IN MILLIONS, EXCEPT PER SHARE AMOUNTS) NET SALES ...................................... $ 283 $ 266 $ 869 $ 818 COSTS AND EXPENSES Cost of products sold .......................... 237 216 719 670 Selling, general and administrative ............ 22 16 61 45 Depreciation and amortization .................. 21 18 58 50 Interest expense ............................... 6 4 17 11 Other (income) expense, net .................... 2 -- (1) 6 Unusual items, net ............................. 2 -- 2 9 ------ ------ ------ ------ INCOME (LOSS) BEFORE INCOME TAXES .............. (7) 12 13 27 Income tax provision (benefit) ................. (4) 4 3 10 ------ ------ ------ ------ NET INCOME (LOSS) .............................. $ (3) $ 8 $ 10 $ 17 ====== ====== ====== ====== EARNINGS (LOSS) PER SHARE OF COMMON STOCK Basic .......................................... $(0.07) $ 0.19 $ 0.23 $ 0.40 ====== ====== ====== ====== Diluted ........................................ $(0.07) $ 0.19 $ 0.23 $ 0.40 ====== ====== ====== ====== Weighted average shares of common stock outstanding ................................. 43.5 42.9 43.2 42.8 ====== ====== ====== ====== Weighted average shares of common stock outstanding, assuming dilution .............. 43.5 51.4 43.3 43.2 ====== ====== ====== ====== DIVIDENDS DECLARED PER SHARE OF COMMON STOCK ... $ 0.03 $ 0.03 $ 0.09 $ 0.09 ====== ====== ====== ======
See Notes to Unaudited Condensed Consolidated Financial Statements.

-1-


GenCorp Inc.
Condensed Consolidated Balance Sheets

          
   February 28, November 30,
   2003 2002
   
 
   (Unaudited)    
   (Dollars in millions,
   except per share amounts)
Current Assets
        
Cash and cash equivalents $45  $48 
Accounts receivable  140   139 
Inventories, net  178   167 
Recoverable from the U.S. Government and other third parties for environmental remediation costs  24   24 
Deferred income taxes  4    
Prepaid and other expenses  12   5 
   
   
 
 Total Current Assets  403   383 
Noncurrent Assets
        
Property, plant and equipment, net  482   481 
Recoverable from the U.S. Government and other third parties for environmental remediation costs  205   208 
Deferred income taxes     9 
Prepaid pension asset  341   337 
Goodwill  132   126 
Other noncurrent assets, net  94   92 
   
   
 
 Total Noncurrent Assets  1,254   1,253 
   
   
 
 Total Assets $1,657  $1,636 
   
   
 
Current Liabilities
        
Short-term borrowings and current portion of long-term debt $21  $22 
Accounts payable  87   89 
Reserves for environmental remediation  39   39 
Income taxes payable  17   22 
Current deferred income taxes     1 
Other current liabilities  201   200 
   
   
 
 Total Current Liabilities  365   373 
Noncurrent Liabilities
        
Convertible subordinated notes  150   150 
Other long-term debt, net of current portion  226   215 
Reserves for environmental remediation  297   301 
Postretirement benefits other than pensions  172   176 
Deferred income taxes  1    
Other noncurrent liabilities  67   61 
   
   
 
 Total Noncurrent Liabilities  913   903 
   
   
 
 Total Liabilities  1,278   1,276 
   
   
 
Commitments and Contingent Liabilities
Shareholders’ Equity
        
Preference stock, par value of $1.00 per share; 15 million shares authorized; none issued or outstanding      
Common stock, par value of $0.10 per share; 150 million shares authorized; 43.7 million shares issued, 43.0 million outstanding as of February 28, 2003 (43.5 million shares issued, 43.0 million shares outstanding as of November 30, 2002)  4   4 
Other capital  13   13 
Retained earnings  358   356 
Accumulated other comprehensive income (loss), net of income taxes  4   (13)
   
   
 
 Total Shareholders’ Equity  379   360 
   
   
 
 Total Liabilities and Shareholders’ Equity $1,657  $1,636 
   
   
 

GENCORP INC. CONDENSED CONSOLIDATED BALANCE SHEETS
AUGUST 31, NOVEMBER 30, 2003 2002 --------- ----------- (DOLLARS IN MILLIONS) CURRENT ASSETS Cash and cash equivalents............................................................. $ 61 $ 48 Accounts receivable................................................................... 113 139 Inventories, net...................................................................... 183 167 Recoverable from the U.S. Government and other third parties for environmental remediation ......................................................... 24 24 Prepaid expenses and other............................................................ 12 5 --------- -------- Total Current Assets.......................................................... 393 383 NONCURRENT ASSETS Restricted cash....................................................................... 95 - Property, plant and equipment, net.................................................... 473 481 Recoverable from the U.S. Government and other third parties for environmental remediation ......................................................... 192 208 Deferred income taxes................................................................. - 9 Prepaid pension asset................................................................. 349 337 Goodwill, net......................................................................... 132 126 Other noncurrent assets, net.......................................................... 103 92 --------- -------- Total Assets.................................................................. $ 1,737 $ 1,636 ========= ======== CURRENT LIABILITIES Short-term borrowings and current portion of long-term debt........................... $ 44 $ 22 Accounts payable...................................................................... 77 89 Reserves for environmental remediation................................................ 39 39 Income taxes payable.................................................................. 15 22 Current deferred income taxes ........................................................ - 1 Other current liabilities............................................................. 200 200 --------- -------- Total Current Liabilities..................................................... 375 373 NONCURRENT LIABILITIES Other long-term debt, net of current portion.......................................... 161 215 Convertible subordinated notes........................................................ 150 150 Senior subordinated notes............................................................. 150 - Reserves for environmental remediation................................................ 278 301 Postretirement benefits other than pensions........................................... 165 176 Other noncurrent liabilities.......................................................... 65 61 --------- -------- Total Noncurrent Liabilities.................................................. 969 903 COMMITMENTS AND CONTINGENT LIABILITIES SHAREHOLDERS' EQUITY Preference stock, par value of $1.00 per share; 15.0 million shares authorized; none issued or outstanding......................................................... - - Common stock, par value of $0.10 per share; 150.0 million shares authorized; 44.1 million shares issued, 43.6 million shares outstanding as of August 31, 2003 (43.5 million shares issued, 43.0 million shares outstanding as of November 30, 2002)................................................................. 4 4 Other capital......................................................................... 17 13 Retained earnings..................................................................... 362 356 Accumulated other comprehensive income (loss), net of income taxes.................... 10 (13) --------- -------- Total Shareholders' Equity.................................................... 393 360 --------- -------- Total Liabilities and Shareholders' Equity.................................... $ 1,737 $ 1,636 ========= ========
See Notes to Unaudited Condensed Consolidated Financial Statements.

-2-


GenCorp Inc.

Condensed Consolidated Statements of Cash Flows
(Unaudited)

            
     Three months ended
     February 28,
     
     2003 2002
     
 
     (Dollars in millions)
Operating Activities
        
Net income $3  $3 
Adjustments to reconcile net income to net cash used in operating activities:        
 Net loss related to reacquisition of minority ownership interest in subsidiary     2 
 Depreciation and amortization and gains on disposition of assets  18   16 
 Deferred income taxes  8   (4)
 Changes in assets and liabilities, net of effects of acquisitions of businesses:        
  Current assets  (11)  26 
  Noncurrent assets  (1)  1 
  Current liabilities  (24)  (24)
  Noncurrent liabilities  (6)  (23)
   
   
 
   Net Cash Used in Operating Activities  (13)  (3)
Investing Activities
        
Capital expenditures  (9)  (6)
Proceeds from asset dispositions  7    
Acquisition of businesses, net of cash acquired     (8)
   
   
 
   Net Cash Used in Investing Activities  (2)  (14)
Financing Activities
        
Borrowings on revolving credit facility, net  15   3 
Net short-term debt repayments     (2)
Net proceeds from the issuance of long-term debt  (5)  25 
Dividends paid  (1)  (1)
Other equity transactions     1 
   
   
 
   Net Cash Provided by Financing Activities  9   26 
   
   
 
Effect of exchange rate fluctuations on cash and cash equivalents  3   1 
   
   
 
Net (Decrease) Increase in Cash and Cash Equivalents
  (3)  10 
Cash and Cash Equivalents at Beginning of Period  48   44 
   
   
 
Cash and Cash Equivalents at End of Period $45  $54 
   
   
 

GENCORP INC. CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
NINE MONTHS ENDED AUGUST 31, 2003 2002 ---------- -------- (DOLLARS IN MILLIONS) OPERATING ACTIVITIES Net income............................................................................ $ 10 $ 17 Adjustments to reconcile net income to net cash provided by (used in) operating activities: Net loss related to reacquisition of minority ownership interest in subsidiary................................................................. - 2 Gain on sale of property, plant and equipment................................... (10) - Foreign exchange gain........................................................... (2) - Depreciation and amortization................................................... 58 50 Deferred income taxes........................................................... 8 15 Changes in assets and liabilities, net of effects of acquisitions of businesses: Current assets............................................................. 12 36 Noncurrent assets.......................................................... (2) (112) Current liabilities........................................................ (34) (101) Noncurrent liabilities..................................................... (33) 53 ---------- -------- Net Cash Provided by (Used in) Operating Activities.................... 7 (40) INVESTING ACTIVITIES Capital expenditures.................................................................. (36) (31) Restricted cash....................................................................... (95) - Proceeds from sale of property, plant and equipment................................... 20 4 Acquisition of businesses, net of cash acquired....................................... - (8) ---------- --------- Net Cash Used in Investing Activities.................................. (111) (35) FINANCING ACTIVITIES Proceeds from issuance of subordinated notes.......................................... 150 150 Repayments on revolving credit facility, net.......................................... (45) (60) Net short-term debt (repaid) incurred................................................. 21 (6) Proceeds from the issuance of long-term debt.......................................... 6 25 Repayments of long-term debt.......................................................... (14) (37) Debt issuance costs................................................................... (5) (6) Dividends paid........................................................................ (4) (4) Other equity transactions............................................................. 4 4 --------- -------- Net Cash Provided by Financing Activities.............................. 113 66 --------- -------- Effect of exchange rate fluctuations on cash and cash equivalents..................... 4 2 --------- -------- NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS.................................. 13 (7) Cash and Cash Equivalents at Beginning of Period...................................... 48 44 --------- -------- Cash and Cash Equivalents at End of Period............................................ $ 61 $ 37 ========= ========
See Notes to Unaudited Condensed Consolidated Financial Statements.

-3-


GenCorp Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

GENCORP INC. NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 1. Basis of Presentation and Nature of Operations

BASIS OF PRESENTATION AND NATURE OF OPERATIONS The accompanying Unaudited Condensed Consolidated Financial Statements of GenCorp Inc. (GenCorp or the Company) include the accounts of the parent company and its wholly-owned and majority-owned subsidiaries. These interim financial statements have been prepared in accordance with the instructions to Form 10-Q and therefore do not include all of the information and notes required by accounting principles generally accepted in the United States. These interim financial statements should be read in conjunction with the financial statements and accompanying notes included in the GenCorp Annual Report on Form 10-K for the year ended November 30, 2002, as filed with the United States Securities and Exchange Commission (SEC).

In the opinion of management, the accompanying Unaudited Condensed Consolidated Financial Statements reflect all adjustments consisting only of normal recurring accruals, necessary for a fair presentation of the Company’sCompany's financial position, results of operations and cash flows for the periods presented. During the third quarter of 2003, the Company's GDX Automotive recorded a $3 million charge related to the correction of accounting for certain customer pricing allowances and vendor rebates, which individually and in the aggregate, were not material to the periods in which they were initially recorded. All significant intercompany balances and transactions have been eliminated in consolidation. The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. In addition, our operating results for interim periods may not be indicative of the results of operations for a full year.

Certain reclassifications have been made to financial information for prior periods to conform to the current period’speriod presentation.

     Headquartered in Sacramento, California, the Company GenCorp is a multinational manufacturing and engineering company operating primarily in North America and Europe. The Company’s continuingCompany's operations are organized into three segments: GDX Automotive, Aerospace and Defense, and Fine Chemicals. The Company’sCompany's GDX Automotive segment is a major automotive supplier, engaged in the development manufacture and salemanufacture of highly engineered extruded and molded rubber and plastic sealing systems for vehicle bodies and windows for automotive original equipment manufacturers. The Aerospace and Defense segment includes the operations of Aerojet-General Corporation (Aerojet or AGC). Aerojet’s business primarily serves high technology markets that include and development activities related to real property located in California. Aerojet designs, develops and manufactures space and strategic rocket propulsion and tactical weapons. Primary customers served includeweapons under contracts with the major prime contractors to the U.S. government, the Department of Defense and the National Aeronautics and Space Administration. In October 2002, Aerojet acquired the assets of the General Dynamics Space Propulsion and Fire Suppression business for $93 million, including transaction costs. -4- In May 2003, Aerojet entered into an agreement to acquire substantially all of the assets related to the propulsion business of Atlantic Research Corporation (ARC Propulsion), for $133 million plus transaction costs. ARC Propulsion is a developer and manufacturer of advanced solid rocket propulsion systems, gas generators and auxiliary rocket motors for both space and defense applications. Aerojet expects to receive regulatory approval and complete its acquisition of ARC Propulsion in October 2003. The Company also has significant undeveloped real estate holdingsacquisition will be funded with the proceeds of the $150 million senior subordinated notes offering completed in California.August 2003 (Note 7), a portion of the proceeds of which were used to temporarily repay borrowings under the Company's revolving credit facility pending completion of the acquisition. The Company’s real estate activities are a component of its Aerospace and Defense segment. The Company’sCompany's Fine Chemicals segment consists of the operations of Aerojet Fine Chemicals LLC (AFC). AFC’s sales are derived primarily from the sale of custom manufacturedAFC manufactures active pharmaceutical ingredients and advanced/registered intermediates tofor pharmaceutical and biotechnology companies. Information on the Company’sCompany's operations by segment is provided in Note 11.

-4-


12. 2. Earnings Per Share of Common Stock

EARNINGS (LOSS) PER SHARE OF COMMON STOCK A reconciliation of the numerator and denominator used to calculate basic and diluted earnings per share of common stock (EPS) is presented in the following table (in(dollars in millions, except per share amounts)amounts; shares in thousands):

          
   Three months ended February 28,
   
   2003 2002
   
 
Numerator for Basic and Diluted EPS
        
 Net income $3  $3 
   
   
 
Denominator for Basic EPS
        
 Weighted average shares of common stock outstanding  43.0   42.7 
   
   
 
Denominator for Diluted EPS
        
 Weighted average shares of common stock outstanding  43.0   42.7 
 Employee stock options     .4 
 Other  .1    
   
   
 
   43.1   43.1 
   
   
 
Basic EPS $0.07  $0.07 
   
   
 
Diluted EPS $0.07  $0.07 
   
   
 

THREE MONTHS ENDED AUGUST 31, NINE MONTHS ENDED AUGUST 31, 2003 2002 2003 2002 -------- -------- -------- -------- NUMERATOR FOR BASIC EPS Net income (loss) ............................ $ (3) $ 8 $ 10 $ 17 ======== ======== ======== ======== NUMERATOR FOR DILUTED EPS Net income (loss) ............................ $ (3) $ 8 $ 10 $ 17 Interest on convertible notes ................ -- 1 -- -- -------- -------- -------- -------- $ (3) $ 9 $ 10 $ 17 ======== ======== ======== ======== DENOMINATOR FOR BASIC EPS Weighted average shares of common stock outstanding ............................ 43,478 42,919 43,234 42,788 ======== ======== ======== ======== DENOMINATOR FOR DILUTED EPS Weighted average shares of common stock outstanding ............................ 43,478 42,919 43,234 42,788 Employee stock options ....................... -- 320 41 410 Convertible notes ............................ -- 8,143 -- -- Other ........................................ -- -- 2 -- -------- -------- -------- -------- 43,478 51,382 43,277 43,198 ======== ======== ======== ======== BASIC EPS ........................................ $ (0.07) $ 0.19 $ 0.23 $ 0.40 ======== ======== ======== ======== DILUTED EPS ...................................... $ (0.07) $ 0.19 $ 0.23 $ 0.40 ======== ======== ======== ========
The effect of athe conversion of the Company’sCompany's $150 million convertible subordinated notes into common stock was not included in the computation of diluted earnings per share for the threenine months ended February 28,August 31, 2002 and the three and nine months ended August 31, 2003 because the effect would be antidilutive for the period.these periods. These notes were issued April 5 and April 17, 2002 and are convertible at an initial conversion rate of 54.29 shares per $1,000 principal amount outstanding. Potentially dilutive securities that are not -5- included in the diluted EPS calculation because they would be antidilutive also include 3,229,000 and 542,000 employee stock options as of February 28,3,644,518 and 740,584 for the three months ended August 31, 2003 and 2002, respectively, and 2,947,089 and 639,614 employee stock options for the nine months ended August 31, 2003 and 2002, respectively.

3. Inventories

           
    February 28, November 30,
    2003 2002
    
 
    (Millions)
Raw materials and supplies $31  $32 
Work-in-process  15   16 
Finished goods  14   15 
   
   
 
Approximate replacement cost of inventories  60   63 
LIFO reserves  (4)  (4)
   
   
 
   56   59 
Long-term contracts at average cost  179   164 
Progress payments  (57)  (56)
   
   
 
 Inventories $178  $167 
   
   
 

-5-


STOCK BASED COMPENSATION As permitted by Statement of Financial Accounting Standards No. 123 (SFAS 123), Accounting for Stock-Based Compensation and Statement of Financial Accounting Standards No. 148 (SFAS 148), Accounting for Stock-Based Compensation - - Transition and Disclosure, the Company applies the existing accounting rules under APB Opinion No. 25, Accounting for Stock Issued to Employees, which provides that no compensation expense is charged for options granted at an exercise price equal to the market value of the underlying common stock on the date of grant. Had compensation expense for the Company's stock option plans been determined based upon the fair value at the grant date for awards under these plans using market-based option valuation models, net income (loss) and the effect on net income (loss) per share would have been as follows (dollars in millions, except per share amounts):
THREE MONTHS ENDED AUGUST 31, NINE MONTHS ENDED AUGUST 31, 2003 2002 2003 2002 ------------ ------------ ------------ ------------ Net income (loss), as reported ..................... $ (3) $ 8 $ 10 $ 17 Add: Stock based compensation expense reported, net of related tax effects ........... -- 1 -- 1 Deduct: Stock based compensation expense determined under fair value based method for all awards, net of related tax effects ..... -- (1) (1) (2) ------------ ------------ ------------ ------------ Net income (loss), pro forma ....................... $ (3) $ 8 $ 9 $ 16 ============ ============ ============ ============ As reported Basic .............................................. $ (0.07) $ 0.19 $ 0.23 $ 0.40 ============ ============ ============ ============ Diluted ............................................ $ (0.07) $ 0.19 $ 0.23 $ 0.40 ============ ============ ============ ============ Pro forma Basic .............................................. $ (0.07) $ 0.18 $ 0.21 $ 0.39 ============ ============ ============ ============ Diluted ............................................ $ (0.07) $ 0.18 $ 0.21 $ 0.38 ============ ============ ============ ============
Option valuation models require the input of highly subjective assumptions including the expected stock price volatility. Because the Company's employee stock options have characteristics significantly different from those of traded options and because changes in the input assumptions can materially affect the fair value estimate, it is the Company's opinion that the existing models do not necessarily provide a reliable single measure of the fair value of the employee stock options. -6- 4. Property, Plant and Equipment

          
   February 28, November 30,
   2003 2002
   
 
   (Millions)
Land $50  $50 
Buildings and improvements  298   299 
Machinery and equipment  732   708 
Construction-in-progress  29   23 
   
   
 
   1,109   1,080 
Less: accumulated depreciation  (627)  (599)
   
   
 
 Total property, plant and equipment, net $482  $481 
   
   
 

INVENTORIES
AUGUST 31, NOVEMBER 30, 2003 2002 --------- ----------- (MILLIONS) Raw materials and supplies..................... $ 32 $ 32 Work-in-process................................ 19 16 Finished goods................................. 13 15 --------- -------- Approximate replacement cost of inventories.... 64 63 LIFO reserves.................................. (4) (4) --------- -------- 60 59 Long-term contracts at average cost............ 180 164 Progress payments.............................. (57) (56) --------- -------- Inventories................................ $ 183 $ 167 ========= ========
5. Other Current Liabilities

          
   February 28, November 30,
   2003 2002
   
 
   (Millions)
Accrued liabilities for goods and services $89  $95 
Advanced payments on contracts  10   6 
Accrued compensation and employee benefits  34   37 
Other postretirement benefits  29   29 
Other  39   33 
   
   
 
 Total other current liabilities $201  $200 
   
   
 

PROPERTY, PLANT AND EQUIPMENT
AUGUST 31, NOVEMBER 30, 2003 2002 --------- ----------- (MILLIONS) Land........................................... $ 50 $ 50 Buildings and improvements..................... 281 299 Machinery and equipment........................ 744 708 Construction-in-progress....................... 43 23 --------- -------- 1,118 1,080 Less: accumulated depreciation................. (645) (599) --------- -------- Total property, plant and equipment, net... $ 473 $ 481 ========= ========
6. Long-term Debt

          
   February 28, November 30,
   2003 2002
   
 
   (Millions)
Revolving credit facility $60  $45 
Term Loan A  66   71 
Term Loan B  115   115 
Convertible subordinated notes  150   150 
Other  6   6 
   
   
 
 Total debt  397   387 
Less: amounts due within one year  (21)  (22)
   
   
 
 Long term debt $376  $365 
   
   
 

OTHER CURRENT LIABILITIES
AUGUST 31, NOVEMBER 30, 2003 2002 --------- ----------- (MILLIONS) Accrued liabilities for goods and services..... $ 83 $ 95 Advanced payments on contracts................. 8 6 Accrued compensation and employee benefits..... 34 37 Other postretirement benefits.................. 29 29 Other.......................................... 46 33 --------- -------- Total other current liabilities............ $ 200 $ 200 ========= ========
-7- 7. LONG-TERM DEBT
AUGUST 31, NOVEMBER 30, 2003 2002 ---- ---- (MILLIONS) Senior credit facility: Revolving credit facility ............. $ -- $ 45 Term loan A ........................... 57 71 Term loan B ........................... 114 115 Senior subordinated notes ................. 150 -- Convertible subordinated notes ............ 150 150 Other ..................................... 34 6 ----- ----- Total debt ........................... 505 387 Less: amounts due within one year ......... (44) (22) ----- ----- Long-term debt ........................ $ 461 $ 365 ===== =====
As of February 28,August 31, 2003, the borrowing limit under the revolving credit facility was $137 million,million. As of whichAugust 31, 2003, the Company had drawn down $60 million,no borrowings outstanding and had outstanding letters of credit outstanding of $55 million. The Company has borrowing capability totaling $34 million on additional credit facilities in Europe and Canada, under which $19 million was outstanding as of August 31, 2003 (included in other debt in the table above). Availability under the Company's various credit facilities totaled $97 million as of August 31, 2003. The average interest rate on the outstanding balance of long termlong-term debt was 5.306.6 percent. As of February 28,August 31, 2003, the Company was in compliance with its long-term debt covenants.

On August 11, 2003, the Company sold $150 million aggregate principal amount of senior subordinated notes due August 2013 in a private placement pursuant to Rule 144A under the Securities Act of 1933. Interest on the senior subordinated notes accrues at a rate of 9-1/2% per annum and is payable on August 15 and February 15, beginning February 15, 2004. All or any portion of the senior subordinated notes may be redeemed by the Company on or after August 15, 2008 at redemption prices beginning at 104.75% and reducing to 100.00% by 2011. The senior subordinated notes are unsecured and subordinated to all of the Company's existing and future senior indebtedness, including borrowings under its senior credit facility. The terms of the senior subordinated notes include certain restrictive covenants, that, among other things, limit the incurrence of additional indebtedness, certain restricted payments, asset sales, stock dividends, investments and mergers and consolidations. The senior subordinated notes are fully and unconditionally guaranteed on a senior subordinated unsecured basis by the Company's material domestic subsidiaries. In connection with the issuance of the senior subordinated notes and the ARC Propulsion acquisition, the Company obtained the consent of lenders to an amendment and waiver under its senior credit facility. The amendment and waiver, among other things, permitted the issuance of the senior subordinated notes and, subject to certain limitations, provides for use of the proceeds to finance the purchase price of the ARC acquisition. The amendment and waiver also amended certain of the financial and other covenants contained in the senior credit facility to account for the ARC Propulsion acquisition and the additional indebtedness represented by the senior subordinated notes issued in connection with this acquisition. After the issuance of the senior subordinated notes, the Company obtained the consent of the lenders under its senior credit -8- facility to another amendment under those facilities, which further amended certain financial ratios contained in the senior credit facility and modified the limitations on our use of the net proceeds from the offering pending the completion of the ARC propulsion acquisition. Issuance of the senior subordinated notes generated net proceeds of $145 million after deduction of underwriting discounts and expenses. The Company used approximately $50 million of the net proceeds to repay all of the outstanding indebtedness under the revolving credit facility, which amount may be reborrowed, and intends to use the balance of the net proceeds to finance a portion of the purchase price of the ARC Propulsion acquisition and to pay related fees and expenses. The remainder of the purchase price for the ARC Propulsion acquisition will be financed with borrowings under the revolving credit facility at the time the acquisition closes. Pending completion of the ARC Propulsion acquisition, the remaining net proceeds of $95 million are held in a designated cash account and classified as restricted cash on the Company's balance sheet. Under the terms of the amendment and waiver to the senior credit facility obtained in connection with the issuance of the senior subordinated notes, if the Company does not complete the ARC Propulsion acquisition by December 31, 2003, the Company will be required to use the balance of the net proceeds ($95 million after repayment of the revolving credit facility) to repay in full outstanding indebtedness under term loan A, plus accrued and unpaid interest, with the remainder to be used to repay outstanding indebtedness under term loan B, plus accrued and unpaid interest. Once repaid, the term loan A and term loan B indebtedness may not be reborrowed. Interest Rate Hedging

     As required under the Restated Credit Facility, the The Company entered into interest rate swap agreements effective January 10, 2003 on $100 million of its variable rate term loan debt for a two yeartwo-year period. Under the swap agreements, the Company makes payments based on a fixed rate of 6.02 percent and receives a LIBORLondon InterBank Offered Rate (LIBOR) based variable rate (5.13(4.86 percent as of February 28,August 31, 2003). The interest rate swaps are accounted for as cash flow hedges pursuant to SFASStatement of Financial Accounting Standards No. 133 (SFAS 133), Accounting for

-6-


Derivative Instruments and Hedging Activities,(SFAS 133), and there was no material ineffectiveness recognized in earnings. As of February 28,August 31, 2003, the fair value of these swaps was a liability of $1 million included in other noncurrent liabilities with an offsetting amount recorded as an unrealized loss in other comprehensive income.

7. Commitments and Contingencies

a.     Legal proceedings

8. COMMITMENTS AND CONTINGENCIES A. LEGAL PROCEEDINGS Groundwater Cases

Along with other industrial Potentially Responsible Parties (PRPs) and area water purveyors, Aerojet was sued in 17 cases by approximately 1,500 private plaintiffs residing in the vicinity of the defendants’ manufacturingdefendants' facilities in Sacramento, California, and the Company’sCompany's former facility in Azusa, California. The Azusa cases have been coordinated for trial in Los Angeles, California. The Sacramento cases have been stayed through July 2003. The individual plaintiffs generally seek damages for illness, death, and economic injury allegedly caused by their ingestion of groundwater contaminated or served by defendants, without specifying actual damages. Aerojet and other industrial defendants involved in the -9- litigation are the subject of certain investigations under Thethe Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) and the Resource Conservation and Recovery Act (RCRA).

The Azusa cases, coordinated for trial in Los Angeles, California, are proceeding under two master complaints and pretrial discovery is in process. Because California Public Utilities Commission (PUC) regulated water purveyors cannot be held liable if the water consumed met state and federal quality standards, the Company currently expects the trial court in Los Angeles will hold an evidentiary hearing to determine whether the PUC regulated water entity defendants served water in violation of state or federal drinking water standards. If it is determined that the regulated water purveyors served water not in violation of drinking water standards, the water purveyor defendants will be dismissed from the litigation, potentially leaving the Company and other defendants as remaining parties to assert their defenses. The long-standing stay in the Sacramento cases has been lifted and the parties are stayed at least until July 2003.addressing preliminary pleading issues. Discovery is likely to commence in earnest in 2004. Aerojet has notified its insurers, retained outside counsel and intends to conduct a vigorous defense against all claims.

McDonnell Douglas Environmental Remediation Cost Recovery Dispute

Aerojet and McDonnell Douglas Corporation (MDC), an operating unit of The Boeing Corporation, and AerojetCompany, are engaged in a dispute in federal courtthe U.S. District Court for the Eastern District of California regarding the costs associated with the environmental contamination of the Inactive Rancho Cordova Test Site (IRCTS). In 1961, IRCTS was transferred by Aerojet to a predecessor of MDC and was subsequently reacquired by Aerojet in 1984. The dispute involves the appropriate shares of responsibility for environmental contamination of IRCTS by MDC and Aerojet. TheAn initial federal lawsuit filed by Aerojet against MDC in 1994 was settled under ain 1999 (1999 Settlement Agreement). Pursuant to the 1999 Settlement Agreement, in which Aerojet agreed to participate with MDC in the interim funding of certain remediation efforts at IRCTS, subject to a final cost allocation.

In 2001, there was a disagreement between Aerojet and MDC regarding the interpretation of the 1999 Settlement Agreement. In December 2001, MDC filed a second lawsuit in Federalfederal court alleging that Aerojet’s interpretation of a subsequent cost sharing agreement between the parties was incorrect and constituted a breach ofAerojet breached the 1999 Settlement Agreement.Agreement, McDonnell Douglas Corporation v. Aerojet-General Corporation,, Case No. CIV-01-2245, U.S. District Court, E.D. CA. Under that lawsuit, MDC sought to have Aerojet bear a fifty50 percent interim share (rather than the ten10 percent interim share accepted by Aerojet) of the costs of investigating and remediating offsite perchlorate groundwater contamination, near Mather Field, allegedly associated with activities on IRCTS.

-7-


     During In November 2002, Aerojet and MDC entered into discussions to settle the second lawsuit by renegotiating the temporary allocation of certain costs associated with the environmental contamination at IRCTS. As a consequence of those discussions, Aerojet and MDC haveThe parties reached an agreement in principle allocatingto settle the disputedallocation dispute relating to costs associated with the environmental contamination at IRCTS. While the parties have reached an agreement in principle,However, a formal and complete written agreement resolving the dispute has not yet been completed and therefore has not yet been entered into by MDC and Aerojet.

completed. -10- Air Pollution Toxic Tort Cases

Aerojet and several other defendants have been sued by private homeowners residing in the vicinity of Chino and Chino Hills, California. The cases have been consolidated and are pending in the U.S. District Court for the Central District of California -- Baier, et al. v. Aerojet-General Corporation, et al., Case No. EDCV 00 618VAP (RNBx) CA;Kerr, et al. v. Aerojet-General Corporation, Case No. EDCV 01-19VAP (SGLx),and Taylor, et al. v. Aerojet-General Corporation, et al.,Case No. EDCV 01-106 VAP (RNBx). Plaintiffs generally allege that defendants released hazardous chemicals into the air at their manufacturing facilities, which allegedly caused illness, death, and economic injury. Various motions have reduced the number of plaintiffs from 80 to 48. Discovery is proceeding in the cases. Aerojet has notified its insurers and is vigorously defending the actions.

Water Entity Cases

In October 1999, Aerojet was sued by American States Water Company (ASWC), a local water purveyor, and certain of its affiliates seekingfor damages, including unspecified past costs, and replacement water for contaminated drinking water wells near Aerojet’sAerojet's Sacramento, California, manufacturing facility.facility and other future damages. American States Water Company, et al. v. Aerojet-General Corporation, et al., Case No. 99AS05949, Sacramento County Superior Court. The plaintiffs also sued the State of California for inverse condemnation. While both cases were consolidated in 2001, American States Water Company and the State of California recently entered into two separate settlement agreements to resolve the dispute. The trial court approved the settlementsettlements with the California State Water Resources Control Board; however, an additional hearing is expected prior to the court rendering its decision on whether to approve the settlement withBoard and the Central Valley Regional Water Quality Control Board. DiscoveryBoard (Central Valley RWQCB). Aerojet unsuccessfully opposed the settlement and filed petitions to the Third District Court of Appeals and California Supreme Court seeking to overturn the settlement, claiming the settlement was not in good faith. The appellate courts denied review of the settlement. The trial date scheduled for October 2003 has been ongoingdeferred to November 2003 to permit recently initiated settlement discussions between Aerojet and trialASWC to proceed (Note 15). Of significance to the case is currently scheduledAerojet's recent agreement with the Sacramento County Water Agency (the County) in which Aerojet agreed to commencetransfer all remediated groundwater from its Sacramento California site to the County. Subject to various provisions of the County agreement including approval under California Environmental Quality Act (CEQA), the County will assume responsibility for providing replacement water to ASWC and other impacted water purveyors up to the amount of remediated water Aerojet transferred to the County. Aerojet has also agreed to pay the County approximately $13 million over several years toward the cost of constructing a replacement water supply project. If the amount of Aerojet's transferred water is in Septemberexcess of 2003.

the replacement water provided to the impacted water purveyors, the County has committed to make water available for the development of Aerojet's land in an amount equal to the excess. Separately, between April 2000 and October 2001, six local water agencies and water purveyors sued Aerojet and other named defendants to recover damages relating to alleged contamination of drinking water wells in the Baldwin Park Operable Unit (BPOU) of the San Gabriel Basin Superfund site (BPOU drinking water well lawsuits). The plaintiffs included the San Gabriel Basin Water Quality Authority, the Upper San Gabriel Valley Municipal Water District, the Valley County Water District (Valley), the California Domestic Water Co. and San Gabriel Valley Water Company who were seeking, among other things, funding for a water treatment plant at the La Puente Valley County Water District (La Puente) well field. In January 2001, Aerojet and certain other cooperating potentially responsible parties (PRPs) reimbursed -11- these plaintiffs and one other funding agency $4 million for the cost of the treatment plant. Since that time, Aerojet and the cooperating PRPs have continued to pay all operating and related costs for treatment at the La Puente site. The plaintiffs also sued to recover past costs in placing treatment facilities at the Big Dalton well site in the San Gabriel Basin. Plaintiffs claimed that Aerojet was responsible for

-8-


contamination of their drinking water wells. While Aerojet was served in the case filed by Valley, the case has been inactive. The primary claim in these cases is for the recovery of past and future CERCLA response costs for treatment plants at plaintiffs’plaintiffs' well sites.

All of the BPOU drinking water well lawsuits were settled and dismissed by the plaintiffs without prejudice on or about September 16, 2002 in accordance with a settlement described as the Project Agreement and more fully describeddiscussed below under Santhe heading "San Gabriel Valley Basin, California." The settlement of plaintiffs’plaintiffs' claims was approved by the United States Environmental Protection Agency (EPA). The settlement agreement requires the cooperating PRPs to fund the construction, maintenance and operation of certain water treatment facilities and to reimburse certain costs of the various water purveyors. As a consequence, all the past cost claims in those actions arewere settled and released. While plaintiffs’ claims against Aerojet have been dismissed, Aerojet has filed third party claims against certain of theand other cooperating PRPs and these claims areintend to seek recovery from those PRPs who did not participate in the process of being settled.

settlement. In October 2002, Aerojet, along with approximately 60 other individual and corporate defendants, was recently served with four civil suits filed in the U.S. District Court for the Central District of California that seek recovery of costs allegedly incurred in response to the contamination present at the South El Monte Operable Unit (SEMOU) of the San Gabriel Valley Superfund site. The cases are denominated as follows:The City of Monterey Park v. Aerojet-General Corporation, et al.,(CV-02-5909 (CV-02-5909 ABC (RCx));San Gabriel Basin Water Quality Authority v. Aerojet-General Corporation, et al.,(CV-02-4565 (CV-02-4565 ABC (RCx));San Gabriel Valley Water Company v. Aerojet-General Corporation, et al., (CV-02-6346 ABC (RCx)) andSouthern California Water Company v. Aerojet-General Corporation, et al.,(CV-02-6340 (CV-02-6340 ABC (RCx)). The cases have been coordinated for ease of administration by the court. Aerojet filed its answer to the complaint filed by the San Gabriel Valley Water Quality Authority and motions to dismiss the other three complaints. The March 31, 2003 tentative ruling by the court indicated thatruled on Aerojet's motions to dismiss, and dismissed several alleged causes of action in the complaints will be dismissed.such complaints. The court has not yet rendered a final decision.

     Theseremaining claims are based upon allegations of discharges from a former site in the El Monte area, as more fully discussed below under Santhe heading "San Gabriel Valley Basin, California - South El Monte Operable Unit." Aerojet has notified its insurers and is vigorously defending the actions as its investigations do not identify a credible connection between the contaminants identified by the water entities in the SEMOU and those detected at Aerojet’sAerojet's former facility located in El Monte, California, near the SEMOU (East Flair Drive site).

Aerojet has notified its insurers of these claims. Vinyl Chloride Toxic Tort Cases

Between the early 1950’s1950's and 1985, GenCorp produced polyvinyl chloride (PVC) resin at its former Ashtabula, Ohio facility. PVC is the most common form of plastic currently on the market. A building block compound of PVC is vinyl chloride (VC), now listed as a known carcinogen by several governmental agencies. OSHA has strictly regulated workplace exposure to VC since 1974.

-12- Since 1996,the mid-1990's, GenCorp has been named in 2328 toxic tort cases involving alleged exposure to VC. Thirteen of these cases were filed during 2002. With the exception of one case brought by the family of a former Ashtabula employee, GenCorp is alleged to be a “supplier/manufacturer”"supplier/manufacturer" of PVC and/or a civil co-conspirator with other VC and PVC manufacturers. Plaintiffs generally allege that GenCorp suppressed information about the carcinogenic risk of VC to industry workers, and placed VC or PVC into commerce without sufficient warnings. Of these 2328 cases, ten14 have been settled or

-9-


dismissed on terms favorable to the Company, including the case where GenCorp was the employer. During 2002,2003, one case was dismissed against GenCorp and other alleged co-conspirators because Plaintiffthe plaintiff could not establish any evidence of fraud or conspiracy to commit fraud, and since the case is still pending against the VC exposure.

suppliers, no appeal has been taken. Another case was dismissed in 2003 on statute of limitations grounds and the appeal by the plaintiff in that case was later dismissed. Of the remaining thirteen14 pending cases, there are four2 cases which allege VC exposure through various aerosol consumer products. In these cases, VC is alleged to have been used as an aerosol propellant during the 1960’s,1960's, and the suits name numerous consumer product manufacturers, in addition to more than 30 chemical manufacturers. GenCorp used VC internally, but never supplied VC for aerosol or any other use. The other nine12 cases involve employees at VC or PVC facilities which had no connection to GenCorp.GenCorp, one of which is a class action seeking a medical monitoring program for former employees at a PVC facility in New Jersey. The complaints in each of these cases assert GenCorp’sGenCorp's involvement in the alleged conspiracy in these cases stems from GenCorp’sGenCorp's membership in trade associations. GenCorp is vigorously defending against all claims in these cases.

Asbestos Litigation

Over the years, both GenCorp and Aerojet have from time to time been named as defendants in lawsuits alleging personal injury or death due to exposure to asbestos in building materials or in manufacturing operations. The lawsuits have been filed throughout the country, with the majority filed in Northern California. Since 1998, more than 50 of these asbestos lawsuits have been resolved, with the majority being dismissed and a substantial minoritymany being settled for less than $30 thousand each. Approximately 3035 asbestos cases are currently pending.

In November 2002, a jury verdict against Aerojet in the amount of approximately $5 million in the Circuit Court of the City of St. Louis, Missouri, led to a judgment of approximately $2 million after setoff. The case isGoede et al. v. ChestertunChesterton Inc.,Case No. 012-9428, Circuit Court, City of St. Louis, MO. The $3 million setoff was based on plaintiffs’plaintiffs' settlements with other defendants. Post-trial motions filed by Aerojet and the plaintiffs recentlywere denied by the trial court. Aerojet has filed post-trial motions. Plaintiffs are seekinga notice of appeal and will be asking the appellate court to vacate the judgment and order a new trial to recover punitive damages; andbased on, among other things, the trial court's actions during trial that denied Aerojet is seeking a new trial because the Company was not allowedopportunity to introduce all its evidencetestimony from certain witnesses against plaintiffs’ claims. On March 31, 2003and certain evidence at trial. Aerojet filed its opening brief with the trialappellate court issued its memorandum and order denying plaintiffs’ and the Company’s motions. The Company intends to file an appeal to vacate the judgment.

on September 2, 2003. -13- Wotus, et al. v. GenCorp Inc. and OMNOVA Solutions Inc.

In October 2000, a group of hourly retirees filed a class actionfederal lawsuit disputing retiree medical benefits and namingagainst GenCorp and OMNOVA Solutions Inc. (OMNOVA) as defendants,disputing certain retiree medical benefits. Wotus, et al. v. GenCorp Inc., et al.,U.S.D.C., N.D. OH (Cleveland, OH), Case No. 5:00-CV-2604. The retirees soughtseek rescission of the then current Hourly Retiree Medical Plan established in springthe Spring of 1994, and the reinstatement of the prior plan terms. The crux of the dispute relates to union and GenCorp negotiated modifications into retiree benefits that, in exchange for other consideration, now require retirees to make benefit contributions as a result of caps on Company paidCompany-paid retiree medical costcosts implemented in fallthe Fall of 1993. A retiree’sretiree's failure to pay contributions results in a termination of benefits.

The plaintiffs are seeking class action certification by motion and the briefs have been filed before the trial court. The trial court has not yet ruled on the plaintiffs' motion for class action certification; however, a decision by the court is expected before the end of the second quarter 2004. The putative class representatives currently consist of four hourly retirees from the Jeannette, Pennsylvania facility of OMNOVA, the company spun-off from GenCorp on October 1, 1999, two hourly retirees from OMNOVA’sOMNOVA's former Newcomerstown, Ohio facility, and three hourly retirees from GenCorp’sGenCorp's former tire plants in Akron, Ohio, Mayfield, Kentucky, and Waco, Texas. The

-10-


putative class encompasses all eligible hourly retirees formerly represented by the unions URW or USWA. The unions, however, are not party to the suit and have agreed not to support such litigation pursuant to an agreement negotiated with GenCorp. GenCorp prevailed in a similar class action filed in 1995 involving salaried employees and arising at its Wabash, Indiana location.Divine, et al. v. GenCorp Inc.,U.S.D.C., N.D. IN (South Bend, IN), Case No. 96-CV-0394-AS.

Plaintiff retirees and the Company defendants filed cross-motions for summary judgment which were denied on December 20, 2002. In February 2003, the court approved a case management plan and discovery will proceed throughout most of 2003.

GenCorp has given notice to its insurance carriers and intends to vigorously defend against the retirees’retirees' claims. OMNOVA has requested defense and indemnification from GenCorp should plaintiffs prevail inregarding this matter. GenCorp has denied this request and OMNOVA’s claim will likely be decided through binding arbitration pursuant tothe party-defendants are now engaged in alternative dispute resolution (ADR) proceedings under their agreements entered into during the GenCorp-OMNOVA spin-off in 1999.

GenCorp initiated the arbitration and the parties are in the process of meeting with the selected arbitrator to determining briefing and hearing procedures. Under the ADR process, it is expected that the dispute will be resolved by a ruling of the arbitrator before the end of the second quarter 2004. Olin Corporation v. GenCorp Inc.

In August 1991, Olin Corporation (Olin) advised GenCorp that under a 1962 manufacturing agreement with Olin (1962 Agreement), it believed GenCorp to be jointly and severally liable for certain Superfund remediation costs, estimated by Olin to be $70 million. The costs are associated with a former Olin manufacturing facility and its waste disposal sites in Ashtabula County, Ohio. In 1993, GenCorp sought a declaratory judgment in federal court (Ohio Court) that the Company is not responsible for such environmental remediation costs. Olin counterclaimed seeking a judgment that GenCorp is jointly and severally liable for a share of remediation costs. Olin v. GenCorp hasInc., Case No. 5:93CV2269, U.S. District Court, N.D. Ohio. -14- GenCorp argued and asserted as a defense to Olin’sOlin's counterclaim that under the terms of the 1962 Agreement Olin had a contractual obligation to insure against environmental and other risks and that its failure to protect such insurance payments under these policies precluded Olin from recovery against GenCorp for these remediation costs. Further, GenCorp argued that any failure on Olin’sOlin's part to comply with the terms of such insurance policies would result in GenCorp being entitled to breach of contract remedies resulting in a reduction in any CERCLA liability amounts determined to be owed to Olin that would have otherwise been recovered from Olin’sOlin's insurance carriers (Reduction Claims).

In 1999, the Ohio Court rendered an interim decision on CERCLA liability. The Ohio Court found GenCorp 30 percent liable and Olin 70 percent liable for remediation costs at “Big"Big D Campground”Campground" landfill (Big D site). The Ohio Court also found GenCorp 40 percent liable and Olin 60 percent liable for remediation costs, including costs for off-site disposal (other than the Big D)D site) and costs attributable to contamination at the Olin TDI facility, a plant built and operated by Olin on GenCorp property near the Big D site. On May 9, 2002, the Ohio Court issued a memorandum opinion stating that it intended to enter a judgment in Olin’sOlin's favor in the amount of approximately $19 million, plus prejudgment interest against GenCorp, for CERCLA contribution liability. In that same opinion, the Ohio Court deferred concluding whether and to what extent GenCorp would be entitled to receive a credit against its CERCLA contribution liability based on the Company’sCompany's Reduction Claims against Olin, pending the outcome of Olin’sOlin's litigation against its insurance carriers for coverage under Olin’sOlin's insurance policies.

The Company has appealed its CERCLA contribution liability. The Company believes that it is not directly or indirectly liable as an arranger for Olin’sOlin's waste disposal at the Big D site and that it

-11-


did not either actively control Olin’sOlin's waste disposal choices or operate the plant on a day-to-day basis. Outside counsel have advised the Company that many aspects of the Company’sCompany's appeal of its CERCLA liability have considerable merit. Management believes it will prevail on appeal.

Irrespective of the outcome of its appeal, the Company believes it has contractual protection against Olin’sOlin's claims by virtue of Olin’sOlin's obligations to procure and protect insurance. The Ohio Court had previously resolved that pursuant to the terms of the 1962 Agreement, it was Olin’sOlin's contractual obligation to obtain insurance coverage, and the evidence adduced during the litigation showed that Olin had in place insurance coverage during the period in question in the amount of $40 million to $50 million.

On September 5, 2002, Olin advised the Ohio Court and GenCorp that on August 27, 2002, the U.S. District Court for the Southern District of New York (NY Court) had ruled Olin failed to protect its right to payments under its insurance policies for the Big D site. The NY Court based its ruling on the fact that Olin had failed to timely notify its insurance carriers of its claims. Olin also informed the Ohio Court it would appeal the NY Court decision and pressed the Ohio Court to enter judgment.

If the NY Court decision is affirmed on Olin’sOlin's appeal, the Ohio Court could rule inGenCorp v. Olin Corporationin one of two ways: (a) it could find that Olin’sOlin's late notice constituted a breach of its obligation under the 1962 Agreement to protect the insurance; or (b) it could conclude that Olin’sOlin's conduct does not fully reduce GenCorp’sGenCorp's liability. If the Ohio Court rules that Olin’sOlin's late notice is a breach of the 1962 Agreement, the question will become a determination of the damages suffered by GenCorp as a result of the breach. GenCorp has -15- argued that the proper measure of damages is the coverage limits of the policies that Olin forfeited -- an amount in this case that is more than sufficient to cover GenCorp’sGenCorp's entire liability.

On September 13, 2002, GenCorp filed a motion asking the Ohio Court to reconsider its decision to enter judgment for Olin, or in the alternative, to consider GenCorp’sGenCorp's Reduction Claims that could result in a ruling in favor of GenCorp. The parties exchanged briefs on these issues.

The Ohio Court issued a memorandum opinion and judgment order on November 21, 2002 entering “final”"final" judgment in favor of Olin in the amount of approximately $19 million plus prejudgment interest in the amount of approximately $10 million. However, the Ohio Court did not decide GenCorp’sGenCorp's Reduction Claims against Olin, but did state that two matters related to the Company’sCompany's Reduction Claims were “pivotal”"pivotal" to the ultimate determination of this case: (i) whether there was an insurable event upon which Olin could recover had Olin complied with the applicable contract provisions and (ii) whether GenCorp is entitled to receive a credit based on Olin’sOlin's failure to provide timely notice that foreclosed insurance recovery. The Ohio Court further determined that GenCorp’sGenCorp's Reduction Claims “are"are held in abeyance pending the resolution of [Olin’s][Olin's] appeal in the New York insurance litigation." Management has been advised by outside counsel that GenCorp’sGenCorp's recovery on its Reduction Claims could range from a nominal amount to an amount sufficient to reduce the judgment against GenCorp in its entirety.

Outside counsel to the Company advised that because the Ohio Court’sCourt's opinion and judgment was based on the 1962 Agreement and because the Ohio Court failed to resolve GenCorp’sGenCorp's Reduction Claims against Olin, it was likely that the decision and order issued by the Ohio Court on November 21, 2002 would not be considered a final judgment. Consequently, and in reliance upon

-12-


its outside counsel, the Company believed that it was not likely that a final judgment giving rise to liability had actually occurred. The Company filed its notice of appeal, in any event, to preserve its appellate rights. Given Olin’sOlin's contractual obligation to have obtained and complied with the terms of its insurance policies and the NY Court’sCourt's finding that Olin failed to give proper notice of a claim under these insurance policies, neither management nor outside counsel could then, or at this time, estimate the possible amount of liability arising from this case, if any.

In addition to several procedural motions pending before the Ohio Court since early December 2002, GenCorp asked the Ohio Court to waive the standard bond requirement and stay any attempt to execute on the Ohio Court’sCourt's judgment pending appeal. Olin opposed the stay, but stated it would not oppose a stay if GenCorp posted the normal supersedeas bond. On January 22, 2003, the Ohio Court denied all pending motions and issued a Judgment Order stating the case was “terminated”"terminated" on the Ohio Court’sCourt's docket. However, in its Memorandum Opinion and Order of the same date, the Ohio Court stated “["[w]hether there was an insurable event upon which Olin would have been entitled to recovery had it provided its insurers with timely notice ... and... whether GenCorp is entitled to credit based upon Olin’sOlin's omission which foreclosed insurance recovery for Big D, remain unresolved.

" GenCorp filed its notice of appeal on December 20, 2002. In light of the Ohio Court’sCourt's January 22, 2003 judgment and the accompanying opinion, on January 27, 2003, GenCorp filed a motion to dismiss its appeal on the grounds that the November 21, 2002 and January 22, 2003 orders and judgments were not final. The Company sought an appellate ruling that in effect would have directed the Ohio Court to address GenCorp’sGenCorp's Reduction Claims before entering any final judgment. In addition, GenCorp had motions pending which asked: (i) the appellate court to stay -16- execution without bond pending action on GenCorp’sGenCorp's appeal; and (ii) the Ohio Court to accept a letter of credit in lieu of bond should a bond be required. Olin opposed both. GenCorp’sGenCorp's motions were denied by the Sixth Circuit Court of Appeals on February 13, 2003. GenCorp thereafter decided to postposted a bond and pursueinitiated an appeal of the Ohio Court's partial judgment in the Sixth Circuit, rather than seek further review of the finality issue at that time. The parties have negotiatedsubmitted their briefs to the appeal briefing schedule. GenCorp’sCourt and have requested oral argument, which is expected to be set, if granted, later this year. GenCorp's Reduction Claims portion of the case is on hold pending action by the Second Circuit Court of Appeals on Olin’sOlin's appeal of the August 27, 2002 judgment in favor of its insurance carriers as described above.

above and the appeal of the Ohio Court rulings. In summary, while the Ohio Court has found the Company liable to Olin for a CERCLA contribution payment, the Company has concluded it is not currently appropriate to accrue any additional amount related to that finding because: (a) the Company previously accrued the entire amount of its estimated potential liability for contamination at the Olin TDI facility and related offsite contamination, except for disposal at the Big D site; (b) the Company believes it will prevail on appeal on the basis that it is not derivatively or directly liable as an arranger for disposal at the Big D site, both as a matter of fact and as supported by other case law; and (c) irrespective of whether, upon exhausting all avenues of appeal, there is a finding of CERCLA liability, the Company believes that: (i) if Olin prevails in its appeal of the NY Court ruling, the Company will make no payment to Olin; or (ii) if Olin fails in its appeal, that Olin’sOlin's breach of its contractual obligations to provide insurance will result in a reduction in or elimination of some or all of such liability, and for all these reasons, the possible amount of additional liability arising from this case, if any, cannot be established at this time.

-13-


Other Legal Matters

The Company and its affiliated companies are subject to other legal actions, governmental investigations, and proceedings relating to a wide range of matters in addition to those discussed above. In the opinion of the Company, after reviewing the information whichthat is currently available with respect to such matters and consulting with the Company’sCompany's counsel, any liability which may ultimately be incurred with respect to these other matters is not expected to materially affect the consolidated financial condition of the Company. The effect of the resolution of these matters on results of operations cannot be predicted because any such effect depends on both future results of operations and the amount and timing of the resolution of such matters.

b. Environmental Matters

B. ENVIRONMENTAL MATTERS Sacramento, California

In 1989, a federal district court in California approved a Partial Consent Decree (Decree) requiring Aerojet to conduct a Remedial Investigation/Feasibility Study (RI/FS) of Aerojet’sAerojet's Sacramento, California site. The Decree required Aerojet to prepare a RI/FS report on specific environmental conditions present at the site and alternatives available to remediate such conditions. Aerojet also is required to pay for certain governmental oversight costs associated with Decree compliance. Beginning in the mid 1990s,1990's, the State of California expanded its surveillance of perchlorate and nitrosodimethylamine (NDMA). Under the RI/FS, traces of these chemicals were detected using new testing protocols in public water supply wells near Aerojet’sAerojet's Sacramento site.

-17- Aerojet has substantially completed its efforts under the Decree to determine the nature and extent of contamination at the Sacramento facility. Aerojet has preliminarily identified the technologies that will likely be used to remediate the site and has estimated costs using generic remedial costs from Superfund remediation databases. Aerojet will continue to conduct feasibility studies to refine technical approaches and costs to remediate the site. The remediation costs are principally for design, construction, enhancement and operation of groundwater and soil treatment facilities, ongoing project management and regulatory oversight, and are expected to be incurred over a period of approximately 15 years. Aerojet is also addressing groundwater contamination both on and off its facilities through the development of operable unit feasibility studies. On August 19, 2002, the U.S. Environmental Protection Agency (EPA) issued an administrative order requiring Aerojet to implement the EPA approved remedial action for the Western Groundwater Operable Unit. A nearly identical order was issued by the California Regional Water Quality Control Board, Central Valley (Central Valley RWQCB). A discussion of Aerojet’sAerojet's efforts to estimate these costs is contained below under the heading “Environmental"Environmental Reserves and Estimated Recoveries.

" During the third quarter, Aerojet entered into an agreement with the Sacramento County Water Agency (the County) whereby it agreed to transfer all remediated groundwater from its Sacramento California site to the County. Subject to various provisions of the County agreement including approval under California Environmental Quality Act (CEQA), the County will assume responsibility for providing replacement water to ASWC and other impacted water purveyors up to the amount of remediated water Aerojet transferred to the County. Aerojet has also agreed to pay to the County over several years approximately $13 million toward the cost of constructing a replacement water supply project. If the amount of Aerojet's transferred water is in excess of the replacement water provided to the impacted water purveyors, the County has committed to make water available for the development of Aerojet's land in an amount equal to the excess. The liability for these payments is included in the Company's reserves for environmental remediation. On April 15, 2002, the United States District Court approved and entered a Stipulation and Order Modifying the Partial Consent Decree (Stipulation and Order). Among other things, the Stipulation and Order removed approximately 2,600 acres of Aerojet’sAerojet's property from the requirements of the Decree and from the Superfund site designation, enabling the Company to put the 2,600 acres to more productive use. The stipulated order alsoStipulation and Order (i) requires GenCorp to provide a guarantee of up to $75 million (in addition to a prior $20 million guarantee), to assure that remediation activities at the Sacramento site are fully funded; (ii) requires Aerojet to provide a short-term and long-term plan to replace lost water supplies; and (iii) divides the Superfund site into “Operable Units”"Operable Units" to allow Aerojet

-14-


and the regulatory agencies to more efficiently address and restore priority areas. For the first three years of the Stipulation and Order, the new guarantee is partially offset by financial assurances provided in conjunction with the Baldwin Park Operable Unit (BPOU) agreement (discussed below). Obligations under the $75 million aggregate guarantee are limited to $10 million in any fiscal year. Both the $75 million aggregate guarantee and the $10 million annual limitation are subject to adjustment annually for inflation.

Aerojet leased a portion of its Sacramento facility to Douglas Aircraft for rocket assembly and testing from 1957 to 1961 and sold approximately 3,800 acres, including the formerly leased portion, to Douglas Aircraft in 1961. Aerojet reacquired the property known as the “IRCTS”IRCTS from the MDC, the successor to Douglas Aircraft and now an operating unit of theThe Boeing Corporation,Company, in 1984. Both MDC and Aerojet were ordered to investigate and remediate environmental -18- contamination by certain orders issued in 1991 and 1994 by the California Department of Toxic Substance Control (DTSC) and a similar 1997 order of the Central Valley RWQCB. Aerojet filed suit against MDC to recover costs Aerojet incurred resulting from compliance with the orders(orders. Aerojet-General Corporation v. McDonnell Douglas Corporation, et al.,Case No. CVS 94-1862 WBS JFM).JFM. In 1999, Aerojet and MDC entered into a settlement agreement to allocate responsibility for a portion of the costs incurred under the orders and to negotiate responsibility for the remaining costs. On December 7, 2001, MDC subsequently brought suit against Aerojet in the U.S. District Court for the Eastern District of California alleging breach of the settlement agreement and seeking specific performance and declaratory relief.(McDonnell Douglas Corporation v. Aerojet-General Corporation,Civ.S-01-2245, in the U.S. District Court for the Eastern District of California filed December 7, 2001.) Civ.S-01-2245. The alleged breach involves interpretation of the 1999 settlement agreement and subsequent cost sharing agreement between MDC and Aerojet pertaining to contribution by each company toward investigation and remediation costs ordered by the DTSC and the Central Valley RWQCB. DTSC and the Central Valley RWQCB issued their orders alleging both companies were responsible for environmental contamination allegedly existing at and migrating onto and from the IRCTS site, an approximately 3,800 acre portion of Aerojet’sAerojet's approximately 12,000 acre Sacramento facility.

In November 2002, Aerojet and MDC have tentatively agreedentered into discussions to a settlement ofsettle the second lawsuit by establishing newrenegotiating the temporary allocationsallocation of certain costs subjectassociated with the environmental contamination at IRCTS. The parties reached an agreement in principle to final allocation.

settle the allocation dispute relating to costs associated with the environmental contamination at IRCTS. However, a formal and complete written agreement resolving the dispute has not yet been completed. San Gabriel Valley Basin, California

Baldwin Park Operable Unit

BALDWIN PARK OPERABLE UNIT Aerojet, through its former Azusa, California site, was named by the EPA as a PRP in the portion of the San Gabriel Valley Superfund Site known as the Baldwin Park Operable Unit. A Record of Decision (ROD) regarding regional groundwater remediation was issued and Aerojet and 18 other PRPs received Special Notice Letters requiring groundwater remediation. All of the Special Notice Letter PRPs are alleged to have been a source of volatile organic compounds (VOCs). Aerojet’sAerojet's investigation demonstrated that the groundwater contamination by VOCs is principally upgradient of Aerojet’sAerojet's former property and that lower concentrations of VOC contaminants are present in the soils of Aerojet’s presently and historically owned properties.Aerojet's former property. The EPA contends that of the 19 PRPs identified by the EPA, Aerojet is one of the four largest sources of VOC groundwater contamination at the BPOU. Aerojet contests the EPA’sEPA's position regarding the source of contamination and the number of responsible PRPs.

-15-


In May 1997, as a result of the development of more sensitive measuring methods, perchlorate was detected in wells in the BPOU. NDMA was also detected using newly developed measuring methods. Suspected sources of perchlorate include Aerojet’sAerojet's solid rocket development and manufacturing activities in the 1940s1940's and 1950s,1950's, military ordnance produced by another company at a facility adjacent to the Aerojet facilities in the 1940s,1940's, the burning of confiscated fireworks by local fire departments, and fertilizer used in agriculture. NDMA is a suspected by-productbyproduct of liquid rocket fuel activities by Aerojet in the same time period. ItNDMA is also a contaminant in cutting oils used by many businesses and is found in many foods. In addition, new regulatory standards for a chemical known as 1,4 dioxane require additional treatment.is present and is being treated at the BPOU. Aerojet may be a -19- minor contributor of this chemical. Aerojet has been a leader in the development of new, low cost technologies for the treatment of perchlorate, NDMA and 1,4 dioxane.

On June 30, 2000, the EPA issued a Unilateral Administrative Order (UAO) ordering the PRPs to implement a remedy consistent with the ROD, but still encouraging the PRPs to attempt to negotiate an agreement with the local purveyors. The PRPs agreed to comply.

On November 23, 1999, the California Regional Water Quality Control Board, Los Angeles Region (Los Angeles RWQCB) issued orders to Aerojet and other PRPs to conduct groundwater investigations on their respective sites. As a result, the Los Angeles RWQCB ordered Aerojet to conduct limited soil gas extraction, which Aerojet is implementing, and evaluatingto evaluate remedies for perchlorate contamination in soils.

Following extended negotiations, Aerojet, along with seven other PRPs (collectively, the “Cooperating Respondents”"Cooperating Respondents") signed a Project Agreement in late March 2002 with Water Quality Authority, Watermaster, Valley County Water District, La Puente Valley Water District, San Gabriel Valley Water Company, Suburban Water Systems and California Domestic Water Company (collectively, the Water Entities)"Water Entities"). The Project Agreement became effective on May 9, 2002, following approval by a California Superior Court and the finalization of policy language on the $100 million Baldwin Park Operable Unit Manuscript Environmental Site Liability Policy from Chubb Custom Insurance Company covering certain Project risks.

The basic structure of the Project Agreement is for the Cooperating Respondents to fund and financially assure (in the form of cash or letters of credit) the cost of certain treatment and water distribution facilities to be owned and operated by the Water Entities. Actual funding would be provided by funds placed in escrow at the start of each three-month period to cover anticipated costs for the succeeding quarter.

The Cooperating Respondents will also fund operation and maintenance of treatment facilities (not including ordinary operating expenses of the local water purveyors,Water Entities, certain costs for replacement water that may be incurred by such Water Entities and related administrative costs, collectively, O(collectively, "O&M costs)Costs")). The Cooperating Respondents are required to maintain sufficient financial assurance to cover the estimated O&M Costs for two years. Actual payments for O&M paymentsCosts would be made at the start of each three-month period to cover anticipated costs for the succeeding six-month period. When fully constructed, six treatment facilities will be treating in excess of 25,000 gallons per minute for the purposes of ROD implementation and to provideproviding a potable water supply. The Project Agreement has a term of 15 years. The Project Agreement also settles the past environmental claims of the Water Entities.

-16-


Aerojet and the other Cooperating Respondents have entered into an interim allocation agreement that establishes the interim payment obligations of Aerojet and the remaining Cooperating Respondents for the costs of the Project Agreement. Aerojet anticipates that the partiesCooperating Respondents may seek to mediate final allocation, but, if unsuccessful, litigation could occur. Under the interim allocation, Aerojet is responsible for approximately two-thirds of all project costs, pending completion of any allocation proceeding. All project costs are subject to reallocation among the Cooperating Respondents.

A significant amount of public funding is available to offset project costs. To date, Congress has appropriated approximately $40$47 million (so called Title 16 and Dreier funds), which is potentially available for payment of project costs. All such funding will require Water Quality -20- Authority (WQA) action to allocate funds to the project, which the WQA is currently considering. Based upon WQA preliminary actions to date, Aerojet anticipates that approximately $25$28 million of the funding will have been allocated to the project by the end of 2003 and that additional funds may follow in later years.

As part of the EIS sale to Northrop in October 2001, the EPA approved a Prospective Purchaser Agreement with Northrop to absolve it of pre-closing liability for contamination caused by the Azusa facility, which liability will remain with Aerojet. As part of that agreement, Aerojet agreed to put $40 million into an irrevocable escrow for the BPOU project to fund Aerojet’sAerojet's obligations under the Project Agreement. In addition, GenCorp agreed to provide a $25 million guarantee of Aerojet’sAerojet's obligations under the Project Agreement. During the first three years of the Project Agreement, the GenCorp guarantee is partially offset by other financial assurances provided in conjunction with the Project Agreement.

As part of the agreement to sell the EIS business to Northrop, Aerojet paid the EPA $9 million to be offset against Aerojet’sAerojet's share of the EPA’sEPA's total claimed past costs (EPA now claims past costs are approximately $28 million). A very substantial share of the EPA’sEPA's past costs related to the period prior to 1997 when the sole contamination being considered involved VOCs. Aerojet believes that it is responsible for less than ten percent of these costs. As a result, in the allocation with the other PRPs, Aerojet will seek to recover a significant portion of the $9 million paid to the EPA from the other PRPs. Unresolved at this time is the issue of California’sCalifornia's past costs which were last estimated at approximately $4 million.

Aerojet intends to defend itself vigorously to assure that it is appropriately treated with other PRPs and that costs of any remediation are properly spread overallocated among all users of the San Gabriel Valley aquifer. In addition,PRPs. Aerojet has notified its insurers and is also pursuing claims under its insurance remedies.

policies. On November 9, 2001, GenCorp received a General Notice Letter from the EPA asserting that GenCorp is a PRP for the BPOU. This General Notice Letter was received more than ten years after the General Notice given to GenCorp’sGenCorp's subsidiary, Aerojet. The EPA alleged that in the 1940s1940's and early 1950s GenCorp’s predecessor,1950's GenCorp, then known as The General Tire & Rubber Company, participated in a joint venture with Aerojet Engineering Corporation, a predecessor tonow known as Aerojet-General Corporation, sharing 50 percent of the profits on certain U.S. Navy contracts for JATO rockets and that it had some role in managing the joint venture at the Azusa facility. GenCorp strongly disagrees with the EPA designation. The EPA is factually incorrect; at all times, Aerojet was the sole party that owned or operated the Azusa site during the early production of the JATO rockets. GenCorp strongly disagrees with the EPA’sEPA's PRP designation and plans to resist the designation at every level possible.

-17-


On February 28, 2002, the EPA issued a unilateral First Amended Administrative Order For Remedial Design and Remedial Action (Amended Order) for the BPOU. The Amended Order does not materially alter the obligations of Aerojet under the earlier UAO; however, the Amended Order names GenCorp as a Respondent on the basis of the allegations made in the General Notice Letter. The Amended Order does not require GenCorp to undertake any action unless Aerojet fails to perform its obligations under the UAO. It states that GenCorp is being added to the Amended Order “as"as a backup”backup" to Aerojet’s performance;Aerojet's performance, and it provides that GenCorp is deemed to be in compliance with the Amended Order on the effective date of the Amended Order. The EPA has not claimed since the effective date that GenCorp has any current obligation under the order. Because GenCorp does not believe it was properly designated a PRP at the site, the Company is evaluating an appropriate response to the Amended Orderwould contest should the EPA claim action is required.

South El Monte Operable Unit

-21- SOUTH EL MONTE OPERABLE UNIT On December 21, 2000, Aerojet received an order from the Los Angeles RWQCB requiring a work plan for investigation of Aerojet’sAerojet's former El Monte facility. On January 22, 2001, Aerojet filed an appeal of the order with the Los Angeles RWQCB asserting selective enforcement. The appeal had been held in abeyance pending negotiations with the Los Angeles RWQCB, but due to a two-year limitation on the abeyance period, the appeal was dismissed without prejudice. In March 2001, Aerojet submitted a limited work plan to the Los Angeles RWQCB. On February 21, 2001, Aerojet received a General Notice Letter from the EPA Region IX naming Aerojet as a PRP to the SEMOU of the San Gabriel Valley Superfund site. Aerojet continues to negotiate with the Los Angeles RWQCB for a limited investigation of this former facility. Aerojet has begun the process of obtaining access agreements should the Los Angeles RWQCB approve Aerojet’sAerojet's work plan. Because its appeal was dismissed without prejudice, Aerojet may refile its appeal if negotiations with the Los Angeles RWQCB are unsuccessful.

On April 1, 2002, Aerojet received a special notice letter from the EPA (dated March 28, 2002) that requested Aerojet to enter into negotiations with the EPA regarding the performance of a remedial design and remedial action for the SEMOU. In light of this letter, Aerojet performed a limited site investigation of the East Flair Drive Site. The data collected and summarized in the Field Investigation Report showed that chemicals including TCE and PCE were present in the soil and groundwater at and near the East Flair Drive Site. The Field Investigation Report also showed that the hydraulic gradient at the East Flair Drive Site is oriented toward the northeast. This finding indicates that the site is not a likely source of contamination at the SEMOU, as the ground water flow at the site is away from the SEMOU and not toward it. Given the data indicating that the East Flair Drive Site is not a source of the contamination at the SEMOU, Aerojet requested that the EPA reconsider its issuance of the SEMOU special notice letter.

To date, Aerojet has not received a response to the Field Investigation Report from eitherthe EPA. In early May 2003, Aerojet received a response from the Los Angeles RWQCB orand has subsequently held several meetings with the EPA.Los Angeles RWQCB regarding the work plan. Aerojet also continues to work cooperatively with the Los Angeles RWQCB for a limited investigation of the East Flair Drive Site and with the EPA regarding the SEMOU.

On August 29, 2003, the USEPA issued a Unilateral Administrative Order (UAO) against Aerojet and approximately 40 other parties requiring them to conduct the remedial design and remedial action in the SEMOU. The impact of the UAO on the recipients is not clear as the remedy is already being implemented by the water entities. Aerojet has been served with four civil suits filed in the U.S. District Court for the Central District of California thatby four public and private water companies. The suits seek recovery of costs allegedly incurred in response to the contamination present atin the SEMOU.

-18-


Plaintiffs allege that groundwater in the SEMOU is contaminated with chlorinated solvents that were released into the environment by Aerojet and other parties causing plaintiffs to incur unspecified response costs and other damages. Aerojet's investigations to date have not identified a credible connection between the contaminants identified by the water entities in the SEMOU and those detected at Aerojet's former facility located at 9100 & 9200 East Flair Drive, El Monte, California, which lies in or near the SEMOU. -22- Aerojet was successful in its efforts to eliminate several of the claims initially raised by the water entities. However, other claims remain. Initial discovery requests have been served on the plaintiffs. Other Sites

The Company has studied remediation alternatives for its closed Lawrence, Massachusetts facility, which was primarily contaminated with PCBs, and has begun site remediation and off-site disposal of debris. As part of these remediation efforts, the Company is working with local, state and federal officials and regulatory agencies to return the property to a beneficial use. The time frame for the remediation and redevelopment project is currently estimated to range from two to four years.

The Company is also currently involved, together with other companies, in approximately 22 other Superfund and non-Superfund remediation sites. In many instances, the Company’sCompany's liability and proportionate share of costs have not been determined largely due to uncertainties as to the nature and extent of site conditions and the Company’sCompany's involvement. While government agencies frequently claim PRPs are jointly and severally liable at such sites, in the Company’sCompany's experience, interim and final allocations of liability costs are generally made based on relative contributions of waste. Based on the Company’sCompany's previous experience, its allocated share has frequently been minimal, and in many instances, has been less than one percent. Also, the Company is seeking recovery of its costs from its insurers.

Environmental Reserves and Estimated Recoveries

ENVIRONMENTAL RESERVES AND ESTIMATED RECOVERIES (i) Reserves

The Company periodically preparesconducts complete reexaminations of estimated future remediation costs that could be incurred by the Company. These periodic reexaminations take into consideration the investigative work and analysis of the Company’sCompany's engineers, engineering studies performed by outside consultants, and the advice of its legal staff and outside attorneys regarding the status and anticipated results of various administrative and legal proceedings. In most cases only a range of reasonably possible costs can be estimated. In establishing the Company’sCompany's reserves, the most probable estimated amount is used when determinable and the minimum is used when no single amount is more probable.

-23- A summary of the Company’sCompany's environmental reserve activity for the nine months ended August 31, 2003, is shown below (in millions):

             
  November 30, 2002     February 28, 2003
  Reserve Expenditures Reserve
  
 
 
Aerojet $318  $3  $315 
Other Sites  22   1   21 
   
   
   
 
Total $340  $4  $336 
   
   
   
 

-19-


NOVEMBER 30, AUGUST 31, 2002 EXPENDITURES 2003 ---- ------------ ---- Aerojet $ 318 $ 21 $ 297 Other sites 22 2 20 -------------- ------------ ------------ Total $ 340 $ 23 $ 317 ============== ============ ============
(ii) Estimated Recoveries

     On January 12, 1999, Aerojet and the U.S. government implemented the October Pursuant to a 1997 Agreement in Principle (Global Settlement) resolving certain prior environmental and facility disagreements, with retroactive effect to December 1, 1998. The Global Settlement covered all environmental contamination at the Sacramento and Azusa sites. Under the Global Settlement, Aerojet and the U.S. government resolved disagreements about an appropriate cost-sharing ratio.which was implemented in 1999 (Global Settlement), up to 88 percent of the environmental costs associated with Aerojet's Sacramento site and its former Azusa site, can be recovered through the establishment of prices for Aerojet's products and services sold to the U.S. government. The Global Settlement contemplates that the cost-sharingcost sharing ratio will continue for a number of years.

     Pursuant to the Global Settlement covering environmental costs associated with Aerojet’s Sacramento site and its former Azusa site, the Company can recover up to 88 percent of its environmental remediation costs for these sites through the establishment of prices for Aerojet’s products and services sold to the U.S. government. The ability of Aerojet to continue recovering these costs from the U.S. government depends on Aerojet’sAerojet's sustained business volume under U.S. government contracts and programs and the relative size of Aerojet’s commercial business.

contracts. In conjunction with the sale of EIS,a business by Aerojet entered into an agreement withto Northrop wherebyGrumman Corporation (Northrop) in 2001, Northrop will reimburse Aerojet will be reimbursed by Northrop for 50 percent of environmental expenditures eligible for recovery under the Global Settlement. Amounts reimbursed are subject to annual limitations, with excess amounts carrying over to subsequent periods, the total of which will not exceed $190 million over the term of the agreement, which ends in 2028.periods. As of February 28,August 31, 2003, $176$171 million in potential future reimbursements was available over the remaining life of the agreement.

Estimated recoveries from the U.S. government and others for environmental remediation costs totaled $216 million at August 31, 2003 and $232 million at November 30, 2002 The effect of the final resolution of environmental matters and the Company’sCompany's obligations for environmental remediation and compliance cannot be accurately predicted due to the uncertainty concerning both the amount and timing of future expenditures. The Company believes, on the basis of presently available information, that the resolution of environmental matters and the Company’sCompany's obligations for environmental remediation and compliance will not have a material adverse effect on the Company’sCompany's results of operations, liquidity or financial condition. The Company will continue its efforts to mitigate past and future costs through pursuit of claims for recoveries from insurance coverage and other PRPs and continued investigation of new and more cost effective remediation alternatives and associated technologies.

8. Arrangements 9. ARRANGEMENTS WITH OFF-BALANCE SHEET RISK As of August 31, 2003, obligations required to be disclosed in accordance with Off-Balance Sheet Risk

     In November 2002, the FASB issued Interpretation No. 45, (FIN 45 or the Interpretation),Guarantor’sGuarantor's Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of the Indebtedness of Others, which clarifies the requirements consisted of: -24- - - $55 million in outstanding commercial letters of Statementcredit expiring in 2003 and 2004 and securing obligations for environmental remediation, insurance coverage and litigation. - - Up to $120 million aggregate in guarantees by GenCorp of Financial Accounting Standards No. 5 (SFAS 5),AccountingAerojet's obligations to government agencies for Contingencies, relating to a guarantor’s accounting for and disclosures of certain guarantees. FIN 45 requires a guarantor to recognize, at the inception of a guarantee, a liability for the fair value of the obligation undertaken by issuing the guarantee. FIN 45 elaborates on the existing disclosure requirements for most guarantees. It also clarifies that at the time a company issues certain types of guarantees, the company must recognize an initial liability for the fair value, or market value, of the obligations it assumes under the guarantee and must disclose that information in its interim and annual financial statements. The Interpretation’s initial recognition and measurement provisions do not apply to certain agreements which areenvironmental remediation activities, subject to the Interpretation’s disclosure requirements only. The initial recognitionpartial offsets for other financial assurances provided in conjunction with these obligations. (See Note 8(b).) - - $36 million in guarantees by GenCorp of bank loans and measurement provisions apply on a

-20-


prospective basis to guarantees issued or modified after December 31, 2002. The adoptionlines of FIN 45 did not have acredit of its subsidiaries. - - Guarantees, jointly and severally, by its material impact on the Company’s resultsdomestic subsidiaries, of operations, financial condition, or liquidityGenCorp's obligations under its bank credit agreements and did not result in the recording of any additional liabilities as of February 28, 2003 associated with guarantees covered by this Interpretation.

     As of February 28, 2003, obligations subject to the Interpretation’s disclosure requirements consisted of:

$55 million in outstanding commercial letters of credit expiring in 2003 and 2004 and securing obligations for environmental remediation, insurance coverage and litigation.
Up to $120 million aggregate in guarantees by GenCorp of Aerojet’s obligations to government agencies for environmental remediation activities, subject to partial offsets for other financial assurances provided in conjunction with these obligations. (See Note 7(b).)
$33 million in guarantees by GenCorp of bank lines of credit of its subsidiaries.
Guarantees, jointly and severally with its subsidiaries, of GenCorp’s obligations under the Restated Credit Facility. (See Note 6.)

9. Shareholders’ Equity

its $150 million senior subordinated notes due August 2013. (See Note 7 and Note 13) 10. SHAREHOLDERS' EQUITY On February 5,July 11, 2003, the Company’sCompany's Board of Directors declared a quarterly dividend of three cents$0.03 per share on the Company’s ten centsCompany's $0.10 par value common stock. The dividends weredividend was paid on February 28,August 29, 2003.

10. Accumulated Other Comprehensive Income, Net of Income Taxes

11. ACCUMULATED OTHER COMPREHENSIVE INCOME, NET OF INCOME TAXES Comprehensive income encompasses net income and other comprehensive income items, which includes all other non-owner transactions and events that change shareholders’shareholders' equity. The Company’sCompany's other comprehensive lossincome includes the effects of foreign currency translation adjustments and the change in the fair value of interest rate swaps (Note 6)(See Note 7). The components of other comprehensive income and the related income tax effects are presented in the following table:

           
    Three months ended
    February 28,
    
    2003 2002
    
 
    (Millions)
Net income $3  $3 
Other comprehensive income, net of income taxes        
 Effects of foreign currency translation adjustments  18   (5)
 Change in fair value of interest rate swap  (1)   
   
   
 
  Total comprehensive income (loss) $20  $(2)
   
   
 

11. Operating Segments and Related Disclosures

THREE MONTHS ENDED AUGUST 31, NINE MONTHS ENDED AUGUST 31, 2003 2002 2003 2002 ---- ---- ---- ---- (MILLIONS) (MILLIONS) Net income (loss) .................................. $ (3) $ 8 $ 10 $ 17 Other comprehensive income (loss), net of income taxes: Effects of foreign currency translation adjustments ............................ (16) 9 24 19 Change in fair value of interest rate swaps 1 -- (1) -- ---- ---- ---- ---- Total comprehensive income (loss) .................. $(18) $ 17 $ 33 $ 36 ==== ==== ==== ====
12. OPERATING SEGMENTS AND RELATED DISCLOSURES The Company’sCompany's continuing operations are organized into three segments based on different products and customer bases: GDX Automotive, Aerospace and Defense, and Fine Chemicals. See(See Note 1 for additional information related to the Company’s operating segments.

-21-


1) The Company evaluates segment performance based on several factors, of which the primary financial measure is segment operating profit. Segment operating profit represents net sales from continuing operations less applicable costs, expenses and provisions for restructuring and unusual items relating to operations. Segment operating profit excludes corporate income and expenses, provisions for unusual items not related to operations, interest expense, income taxes and any minority interest.

           
    Three months ended
    February 28,
    
    2003 2002
    
 
    (Millions)
Net Sales
        
 GDX Automotive $191  $190 
 Aerospace and Defense  63   54 
 Fine Chemicals  17   5 
   
   
 
  $271  $249 
   
   
 
Income (Loss) Before Income Taxes
        
 GDX Automotive $5  $6 
 Aerospace and Defense  9   16 
 Fine Chemicals  2   (3)
   
   
 
  Segment operating profit  16   19 
 Interest expense  (5)  (3)
 Corporate and other expenses, net  (6)  (9)
 Other unusual items     (2)
   
   
 
  $5  $5 
   
   
 

12. New Accounting Pronouncements

-25- In August 2003, the Company completed the sale of an office complex located in Sacramento County, California for $15 million, resulting in a pre-tax gain of $10 million. The Company's real estate activities are included in the Aerospace and Defense segment. During the third quarter of 2003, the Aerospace and Defense segment recorded intersegment sales to the GDX Automotive segment of $2 million. Profit on these sales was not significant.
THREE MONTHS ENDED AUGUST 31, NINE MONTHS ENDED AUGUST 31, 2003 2002 2003 2002 ---- ---- ---- ---- (MILLIONS) (MILLIONS) NET SALES GDX Automotive ...................... $ 174 $ 190 $ 579 $ 589 Aerospace and Defense ............... 99 63 246 201 Fine Chemicals ...................... 12 13 46 28 Intersegment sales elimination ...... (2) -- (2) -- ----- ----- ----- ----- $ 283 $ 266 $ 869 $ 818 ===== ===== ===== ===== INCOME (LOSS) BEFORE INCOME TAXES GDX Automotive ...................... $ (14) $ 5 $ 7 $ 25 Aerospace and Defense ............... 21 14 41 44 Fine Chemicals ...................... 2 3 8 (1) Unusual items ....................... (2) -- (2) (6) ----- ----- ----- ----- Segment operating profit ........ 7 22 54 62 Interest expense .................... (6) (4) (17) (11) Corporate, other expenses and foreign exchange gains and losses ....... (8) (6) (24) (21) Unusual items ....................... -- -- -- (3) ----- ----- ----- ----- $ (7) $ 12 $ 13 $ 27 ===== ===== ===== =====
13. CONDENSED CONSOLIDATING FINANCIAL INFORMATION In connection with the offer and sale of the senior subordinated notes due 2013, the Company is providing condensed consolidating financial information for its material domestic subsidiaries that have guaranteed the senior subordinated notes and for those subsidiaries that have not guaranteed the senior subordinated notes. These wholly owned subsidiary guarantors (principally, Aerojet and AFC) have, jointly and severally, fully and unconditionally guaranteed the senior subordinated notes. The subsidiary guarantees are senior subordinated obligations of each subsidiary guarantor and rank (i) prior in right of payment with all senior indebtedness, (ii) equal in right of payment with all senior subordinated indebtedness and, (iii) senior in right of payment to all subordinated indebtedness, in each case, of that subsidiary guarantor. The subsidiary guarantees are effectively subordinated to any secured indebtedness of the subsidiary guarantor with respect to the assets securing that indebtedness. Absent both default and notice as specified in the Company's senior credit facility and agreements governing the Company's outstanding convertible notes and the senior subordinated notes, there are no restrictions on the Company's ability to obtain funds from its subsidiary guarantors by dividend or loan. -26- The Company has not presented separate financial and narrative information for each of the subsidiary guarantors because it believes that such financial and narrative information would not provide investors with any additional information that would be material in evaluating the sufficiency of the guarantees. Therefore, the following condensed consolidating financial information summarizes the financial position, results of operations and cash flows for the Company's guarantor and non-guarantor subsidiaries. CONDENSED CONSOLIDATING STATEMENTS OF INCOME:
Guarantor Non-guarantor THREE MONTHS ENDED AUGUST 31, 2003 Parent Subsidiaries Subsidiaries Eliminations Consolidated - ---------------------------------- ------ ------------ ------------ ------------ ------------ Net sales $ 46 $ 125 $ 114 $ (2) $ 283 Cost of products sold 43 95 101 (2) 237 Selling, general and administrative 14 2 6 -- 22 Depreciation and amortization 4 9 8 -- 21 Other (income) expense, net -- 4 -- -- 4 Interest expense 3 1 2 -- 6 ----- ----- ----- ----- ----- Income (loss) before income taxes (18) 14 (3) -- (7) Income tax provision (benefit) (6) 3 (1) -- (4) ----- ----- ----- ----- ----- Income (loss) before equity earnings (12) 11 (2) -- (3) Equity earnings of subsidiaries 9 -- -- (9) -- ----- ----- ----- ----- ----- Net Income (Loss) $ (3) $ 11 $ (2) $ (9) $ (3) ===== ===== ===== ===== =====
Guarantor Non-guarantor THREE MONTHS ENDED AUGUST 31, 2002 Parent Subsidiaries Subsidiaries Eliminations Consolidated - ---------------------------------- ------ ------------ ------------ ------------ ------------ Net sales $ 53 $ 95 $118 $-- $266 Cost of products sold 50 67 99 -- 216 Selling, general and administrative 10 1 5 -- 16 Depreciation and amortization 5 6 7 -- 18 Other (income) expense, net (4) 4 -- -- -- Interest expense 1 1 2 -- 4 ---- ---- ---- ---- ---- Income (loss) before income taxes (9) 16 5 -- 12 Income tax provision (benefit) (1) 4 1 -- 4 ---- ---- ---- ---- ---- Income (loss) before equity earnings (8) 12 4 -- 8 Equity earnings of subsidiaries 16 -- -- (16) -- ---- ---- ---- ---- ---- Net Income $ 8 $ 12 $ 4 $(16) $ 8 ==== ==== ==== ==== ====
< -27- CONDENSED CONSOLIDATING STATEMENTS OF INCOME (CONT):
Guarantor Non-guarantor NINE MONTHS ENDED AUGUST 31, 2003 Parent Subsidiaries Subsidiaries Eliminations Consolidated - --------------------------------- ------ ------------ ------------ ------------ ------------ Net sales $ 156 $ 342 $ 373 $ (2) $ 869 Cost of products sold 140 265 316 (2) 719 Selling, general and administrative 42 6 13 -- 61 Depreciation and amortization 13 25 20 -- 58 Other (income) expense, net (9) 7 3 -- 1 Interest expense 8 3 6 -- 17 ----- ----- ----- ----- ----- Income (loss) before income taxes (38) 36 15 -- 13 Income tax provision (benefit) (12) 9 6 -- 3 ----- ----- ----- ----- ----- Income (loss) before equity earnings (26) 27 9 -- 10 Equity earnings of subsidiaries 36 -- -- (36) -- ----- ----- ----- ----- ----- Net Income $ 10 $ 27 $ 9 $ (36) $ 10 ===== ===== ===== ===== =====
Guarantor Non-guarantor NINE MONTHS ENDED AUGUST 31, 2002 Parent Subsidiaries Subsidiaries Eliminations Consolidated - --------------------------------- ------ ------------ ------------ ------------ ------------ Net sales $ 175 $ 293 $ 350 $-- $ 818 Cost of products sold 156 219 295 -- 670 Selling, general and administrative 27 5 13 -- 45 Depreciation and amortization 14 20 16 -- 50 Other (income) expense, net 5 10 -- -- 15 Interest expense 2 3 6 -- 11 ----- ----- ----- ----- ----- Income (loss) before income taxes (29) 36 20 -- 27 Income tax provision (benefit) (10) 14 6 -- 10 ----- ----- ----- ----- ----- Income (loss) before equity earnings (19) 22 14 -- 17 Equity earnings of subsidiaries 36 -- -- (36) -- ----- ----- ----- ----- ----- Net Income $ 17 $ 22 $ 14 $ (36) $ 17 ===== ===== ===== ===== =====
-28- CONDENSED CONSOLIDATING BALANCE SHEETS:
Guarantor Non-guarantor AUGUST 31, 2003 Parent Subsidiaries Subsidiaries Eliminations Consolidated - --------------- ------ ------------ ------------ ------------ ------------ Cash ........................................ $ 18 $ 6 $ 37 $-- $ 61 Accounts receivable ......................... 8 49 56 -- 113 Inventories ................................. 4 149 30 -- 183 Recoverable from the U.S. government and other third parties for environmental remediation costs ........................ -- 24 -- -- 24 Prepaid expenses and other .................. 2 9 1 -- 12 ------- ------ ----- ------- ------ Total current assets ..................... 32 237 124 -- 393 Restricted cash ............................. 95 -- -- -- 95 Property, plant and equipment, net .......... 62 225 186 -- 473 Recoverable from the U.S. government and other third parties for environmental remediation costs ........................ -- 192 -- -- 192 Prepaid pension asset ....................... 145 202 2 -- 349 Goodwill .................................... 22 40 70 -- 132 Intercompany, net ........................... (415) 573 (158) -- -- Other noncurrent assets, net ................ 1,086 85 53 (1,121) 103 ------- ------ ----- ------- ------ Total assets ............................. $ 1,027 $1,554 $ 277 $(1,121) $1,737 ======= ====== ===== ======= ====== Short-term borrowings and current portion of long-term debt ........................... $ 24 $ -- $ 20 $ -- $ 44 Accounts payable ............................ 15 20 42 -- 77 Reserves for environmental remediation ...... 7 32 -- -- 39 Other current liabilities ................... (13) 189 39 -- 215 ------- ------ ----- ------- ------ Total current liabilities ................ 33 241 101 -- 375 Long-term debt, net of current portion ...... 455 -- 6 -- 461 Reserves for environmental remediation ...... 13 265 -- -- 278 Postretirement benefits other than pensions . 100 56 9 -- 165 Other noncurrent liabilities ................ 32 28 5 -- 65 ------- ------ ----- ------- ------ Total liabilities ........................ 633 590 121 -- 1,344 Total shareholders' equity ............... 394 964 156 (1,121) 393 ------- ------ ----- ------- ------ Total liabilities and shareholders' equity $ 1,027 $1,554 $ 277 $(1,121) $1,737 ======= ====== ===== ======= ======
-29- CONDENSED CONSOLIDATING BALANCE SHEETS (CONT):
Guarantor Non-guarantor NOVEMBER 30, 2002 Parent Subsidiaries Subsidiaries Eliminations Consolidated - ----------------- ------ ------------ ------------ ------------ ------------ Cash ........................................ $ -- $ 13 $ 35 $-- $ 48 Accounts receivable ......................... 12 64 63 -- 139 Inventories ................................. 5 131 31 -- 167 Recoverable from the U.S. government and other third parties for environmental remediation costs ........................ -- 24 -- -- 24 Prepaid expenses and other .................. 2 1 2 -- 5 ------- ------ ----- ------- ------ Total current assets ..................... 19 233 131 -- 383 Property, plant and equipment, net .......... 64 242 175 -- 481 Recoverable from the U.S. government and other third parties for environmental remediation costs ........................ -- 208 -- -- 208 Prepaid pension asset ....................... 139 199 (1) -- 337 Goodwill .................................... 22 41 63 -- 126 Intercompany, net ........................... (367) 535 (168) -- -- Other noncurrent assets, net ................ 1,047 82 43 (1,071) 101 ------- ------ ----- ------- ------ Total assets ............................. $ 924 $1,540 $ 243 $(1,071) $1,636 ======= ====== ===== ======= ====== Short-term borrowings and current portion of long-term debt ........................... $ 20 $ -- $ 2 $ -- $ 22 Accounts payable ............................ 17 27 45 -- 89 Reserves for environmental remediation ...... 7 32 -- -- 39 Other current liabilities ................... (1) 176 48 -- 223 ------- ------ ----- ------- ------ Total current liabilities ................ 43 235 95 -- 373 Long-term debt, net of current portion ...... 361 -- 4 -- 365 Reserves for environmental remediation ...... 15 286 -- -- 301 Postretirement benefits other than pensions . 108 60 8 -- 176 Other noncurrent liabilities ................ 37 22 2 -- 61 ------- ------ ----- ------- ------ Total liabilities ........................ 564 603 109 -- 1,276 Total shareholders' equity ............... 360 937 134 (1,071) 360 ------- ------ ----- ------- ------ Total liabilities and shareholders' equity $ 924 $1,540 $ 243 $(1,071) $1,636 ======= ====== ===== ======= ======
-30- CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS:
Guarantor Non-guarantor NINE MONTHS ENDED AUGUST 31, 2003 Parent Subsidiaries Subsidiaries Eliminations Consolidated Net cash provided by (used in) operating activities $ (22) $ 25 $ 4 $ -- $ 7 Cash flows from investing activities: Capital expenditures (7) (9) (20) -- (36) Other investing activities (95) 13 7 -- (75) ----- ---- ---- ---- ----- Net cash provided by (used in) investing activities (102) 4 (13) -- (111) Cash flows from financing activities: Net transfers (to) from parent 49 (36) (13) -- -- Borrowings (repayments) on notes payable and long-term debt 93 -- 20 -- 113 Other financing activities -- -- -- -- -- ----- ---- ---- ---- ----- Net cash provided by (used in) financing activities 142 (36) 7 -- 113 Effect of exchange rate fluctuations on cash and cash equivalents -- -- 4 -- 4 ----- ---- ---- ---- ----- Net increase (decrease) in cash and cash equivalents 18 (7) 2 -- 13 Cash and cash equivalents at beginning of period -- 13 35 -- 48 ----- ---- ---- ---- ----- Cash and cash equivalents at end of period $ 18 $ 6 $ 37 $ -- $ 61 ===== ==== ==== ===== =====
-31- CONDENSED CONSOLIDATING STATEMENTS OF CASH FLOWS (CONT):
Guarantor Non-guarantor NINE MONTHS ENDED AUGUST 31, 2002 Parent Subsidiaries Subsidiaries Eliminations Consolidated Net cash provided by (used in) operating activities $(30) $(27) $ 17 $-- $(40) Cash flows from investing activities: Capital expenditures (10) (13) (8) -- (31) Acquisitions of businesses, net of cash acquired -- -- -- -- -- Other investing activities (8) -- 4 -- (4) ---- ---- ---- ---- ---- Net cash provided by (used in) investing activities (18) (13) (4) -- (35) Cash flows from financing activities: Net transfers (to) from parent (33) 39 (6) -- -- Borrowings (repayments) on notes payable and long-term debt 66 -- -- -- 66 Other financing activities 14 -- (14) -- -- ---- ---- ---- ---- ---- Net cash provided by (used in) financing activities 47 39 (20) -- 66 Effect of exchange rate fluctuations on cash and cash equivalents -- -- 2 -- 2 ---- ---- ---- ---- ---- Net decrease in cash and cash equivalents (1) (1) (5) -- (7) Cash and cash equivalents at beginning of period 1 3 40 -- 44 ---- ---- ---- ---- ---- Cash and cash equivalents at end of period $ -- $ 2 $ 35 $ -- $ 37 ==== ==== ==== ==== ====
14. NEW ACCOUNTING PRONOUNCEMENTS In January 2003, the FASB issued FASB Interpretation No. 46 (FIN 46),Consolidation of Variable Interest Entities, an Interpretation of ARB No. 5151. FIN 46 requires certain variable interest entities to be consolidated by the primary beneficiary of the entity if the equity investors in the entity do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. FIN 46 is effective for all new variable interest entities created or acquired after January 31, 2003. For variable interest entities created or acquired prior to February 1, 2003, the provisions of FIN 46 must be applied for the first interim or annual period beginning after June 15, 2003. The -32- adoption of FIN 46 did not have a material effect on the Company's results of operations, liquidity, or financial condition. In May 2003, the FASB issued Statement of Financial Accounting Standards No. 149 (SFAS 149), Amendment of Statement 133 on Derivative Instruments and Hedging Activities. SFAS 149 is intended to result in more consistent reporting of contracts as either freestanding derivative instruments subject to Statement 133 in its entirely, or as hybrid instruments with debt host contracts and embedded derivative features. SFAS 149 is effective for contracts entered into or modified after June 30, 2003. The adoption of SFAS 149 did not have a material effect on the Company's results of operations, liquidity, or financial condition. In May 2003, the FASB issued Statement of Financial Accounting Standards No. 150 (SFAS 150), Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity. SFAS 150 requires certain financial instruments that embody obligations of the issuer and have characteristics of both liabilities and equity to be classified as liabilities. Many of these instruments previously were classified as equity or temporary equity and, as such, SFAS 150 represents a significant change in practice in the accounting for a number of mandatorily redeemable equity instruments and certain equity derivatives that frequently are used in connection with share repurchase programs. SFAS 150 is effective for all financial instruments created or modified after May 31, 2003, and to other instruments at the beginning of the first interim period beginning after June 15, 2003. The adoption of SFAS 150 did not have a material effect on the Company's results of operations, liquidity, or financial condition. 15. SUBSEQUENT EVENT As discussed in Note 8(a), Aerojet is involved in litigation with ASWC, a local water purveyor who is seeking damages, including unspecified past costs, replacement water for contaminated drinking water wells near Aerojet's Sacramento, California, manufacturing facility and other future damages. The trial date scheduled for October 2003 has been deferred to November 2003 to permit recently initiated settlement discussions to proceed. On October 10, 2003, Aerojet and ASWC entered into a memorandum of understanding that provides an outline for a potential settlement agreement. A final settlement agreement incorporating the terms of the memorandum of understanding is subject to further review and negotiation, regulatory and other approvals and reaching satisfactory agreements with other affected water purveyors. The Company recorded an additional liability of $10 million in the third quarter 2003 for this matter, which represents management's current estimate of the Company's probable liability arising from the potential settlement. The Company also recorded in other current and non-current assets a total of $8 million for the estimated settlement costs recoverable under Aerojet's agreements with the U.S. government and other third parties. The net expense of $2 million has been classified as an unusual charge in the Company's results of operations for the third quarter 2003. ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS The preparation of the consolidated financial statements in conformity with generally accepted accounting principles requires the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could differ from those estimates. In addition, our operating results for interim periods may not be indicative of the results of operations for a full year. This section contains a number of forward - -33- looking statements, all of which are based on current expectations and are subject to risks and uncertainties including those described in this Quarterly Report under the heading "Risk Factors." Actual results may differ materially. This section should be read in conjunction with the GenCorp Annual Report on Form 10-K for the year ended November 30, 2002, and periodic reports subsequently filed with the United States Securities and Exchange Commission (SEC). OVERVIEW GenCorp's operations are organized into three segments: GDX Automotive, Aerospace and Defense, and Fine Chemicals. The Company's GDX Automotive segment is a major automotive supplier, engaged in the development and manufacture of highly engineered extruded and molded rubber and plastic sealing systems for automotive original equipment manufacturers. The Aerospace and Defense segment includes the operations of Aerojet-General Corporation (Aerojet or AGC) and development activities related to real property located in California. Aerojet designs, develops and manufactures space and strategic rocket propulsion and tactical weapons under contracts with the major prime contractors to the U.S. government, the Department of Defense and the National Aeronautics and Space Administration. The segment also includes the Company's real estate development activities. The Company's Fine Chemicals segment consists of the operations of Aerojet Fine Chemicals LLC (AFC). AFC manufactures active pharmaceutical ingredients and registered intermediates for pharmaceutical and biotechnology companies. In October 2002, Aerojet acquired the assets of the General Dynamics Space Propulsion and Fire Suppression business (Redmond, Washington operations) for $93 million, including transaction costs. In May 2003, Aerojet entered into an agreement to acquire substantially all of the assets related to the propulsion business of Atlantic Research Corporation (ARC Propulsion) for $133 million plus transaction costs. ARC Propulsion is a developer and manufacturer of advanced solid rocket propulsion systems, gas generators and auxiliary rocket motors for both space and defense applications. Aerojet expects to receive regulatory approval to complete its acquisition of ARC Propulsion in October 2003. The acquisition will be funded from the proceeds of the $150 million senior subordinated notes offering completed in August 2003. A portion of the proceeds of the senior subordinated notes offering were used to temporarily repay borrowings under the Company's revolving credit facility pending completion of the ARC Propulsion acquisition. RESULTS OF OPERATIONS The following discussion pertains to activity included in the Company's Unaudited Condensed Consolidated Statements of Income, which are contained in Part I, Item 1 of this report. See Note 12 to the Unaudited Condensed Consolidated Financial Statements for financial results for each of the Company's operating segments. Sales for the third quarter 2003 were $283 million compared to $266 million for the third quarter 2002. Sales for the first nine months of 2003 were $869 million compared to $818 million for the first nine months of 2002. These increases reflect Aerojet's acquisition of the Redmond, Washington operations in October 2002, a $15 million real estate sale in August 2003 and favorable currency exchange rates primarily at GDX Automotive. The increases were partially offset by increased customer pricing allowances and lower sales volume at GDX Automotive. -34- The Company recorded a net loss of $3 million, or $0.07 per share, in the third quarter 2003 compared to net income of $8 million, or $0.19 per share, in the third quarter 2002. Net income was $10 million, or $0.23 per share for the first nine months of 2003 compared to $17 million, or $0.40 per share, for the first nine months of 2002. The earnings decline is primarily the result of reduced income from employee retirement benefit plans and a decline in the operating results of GDX Automotive. RESULTS OF OPERATING SEGMENTS GDX AUTOMOTIVE GDX Automotive sales for the third quarter 2003 were $174 million compared to $190 million in the third quarter 2002. Sales for the first nine months of 2003 were $579 million compared to $589 million in the first nine months of 2002. The decreases reflect lower volumes due to major vehicle platform transitions and increased pricing allowances to major customers. The decreases were partially offset by the effect of favorable currency exchange rates of $15 million in the third quarter 2003 and $54 million for the first nine months of 2003. GDX Automotive reported an operating loss of $14 million for the third quarter 2003 compared to operating income of $5 million in the third quarter 2002. The unfavorable third quarter operating results reflect lower sales volumes and increased pricing allowances, increased costs associated with the launch of new vehicle platforms, unscheduled shutdowns due to original equipment manufacturers labor issues in Europe, lower income from employee retirement benefit plans of $2 million, and a $2 million charge for personnel actions taken at GDX Automotive headquarters. In addition, during the third quarter 2003, GDX Automotive recorded a $3 million charge related to the correction of accounting for certain customer pricing allowances and vendor rebates, which individually and in the aggregate, were not material to the periods in which they were initially recorded. Operating profit for the first nine months of 2003 was $7 million compared to $25 million in the first nine months of 2002. The decline in profitability reflected lower sales volumes, increased pricing allowances, the unfavorable third quarter operating results discussed above, and lower income from employee retirement benefit plans of $6 million. However, favorable foreign currency rate effects contributed $2 million in the first nine months of 2003. AEROSPACE AND DEFENSE Aerospace and Defense sales for the third quarter 2003 were $99 million, compared to $63 million in the third quarter 2002. Sales for the first nine months of 2003 were $246 million compared to $201 million for the first nine months of 2002. Contributing to the increase were sales from the Redmond, Washington operations of $16 million for the third quarter 2003 and $42 million for the first nine months of 2003, increased volumes on programs for liquid and solid systems for Missile Defense applications, the Boeing HyFly program and deliveries under the Atlas V program. Third quarter 2003 results also include a $15 million sale of a building complex located in Sacramento County, California. These increases were offset by the timing of various program deliveries, completion of the NASA X-38 De-Orbit Propulsion Stage in the second quarter of 2002, cancellation of the COBRA booster engine program in 2002, and lower sales volumes on various other programs. -35- Operating profit was $21 million for the third quarter 2003 compared to $14 million in the third quarter 2002. For the first nine months of 2003, operating profit was $41 million compared to $44 million for the first nine months of 2002. Results for 2003 reflect a pre-tax gain of $10 million on the sale of a building complex in the third quarter, contributions from the Redmond, Washington operations of $2 million in the third quarter and $5 million in the first nine months, increased sales volumes on programs for liquid and solid systems for Missile Defense applications and lower profit contributions from other programs. Lower income from employee retirement benefit plans also reduced operating profits by $5 million in the third quarter and $15 million in the first nine months of 2003. In the third quarter 2003, Aerojet recorded an unusual charge of $2 million representing the unrecoverable portion of estimated legal settlement costs. See Note 15 of Notes to Unaudited Condensed Consolidated Financial Statements. Aerojet recorded an unusual charge of $6 million in the second quarter 2002 representing the final purchase price adjustment on the 2001 sale of its EIS business. Contract backlog was $696 million as of August 31, 2003, compared to $773 million as of November 30, 2002. Funded backlog, which includes only those contracts for which money has been directly authorized by the U.S. Congress, or for which a firm purchase order has been received by a commercial customer, was $343 million as of August 31, 2003 compared to $416 million as of November 30, 2002. Funding for the Titan program was restructured in the first quarter of 2003, reducing funded backlog by $58 million. Aerojet expects this funding to be incrementally restored in future years. FINE CHEMICALS Fine Chemicals sales for the third quarter 2003 were $12 million compared to $13 million in the third quarter 2002. Sales for the first nine months of 2003 were $46 million compared to $28 million in the first nine months of 2002. As a contract manufacturer and ingredient supplier to pharmaceutical and biotechnology companies, AFC's sales trends reflect, to a certain extent, increasing demand for its customers' end products. Operating profit for the third quarter 2003 was $2 million, compared to $3 million in the third quarter 2002. The decline in third quarter operating profit as compared to the prior year reflects sales volume decreases and changes in product mix. Operating profit for the third quarter 2003 includes $1 million relating to fees paid by a customer for not meeting minimum purchase commitments during the period. For the first nine months of 2003, operating profit was $8 million, compared to a loss of $1 million in the first nine months of 2002. The improvement in operating profit for the first nine months of 2003 reflects higher sales volume and operational improvements. INTEREST AND OTHER EXPENSES Interest expense increased to $6 million in the third quarter 2003 from $4 million in the third quarter 2002. Interest expense for the first nine months of 2003 increased to $17 million from $11 million in the first nine months of 2002. The increase is due primarily to additional debt incurred for the acquisition of the Redmond, Washington operations in October 2002. -36- Corporate and other expenses increased to $8 million in the third quarter 2003 from $6 million in the third quarter 2002. The increase reflects lower income from employee retirement benefit plans of $3 million and a foreign currency loss of $1 million, offset in part by reduced incentive compensation plan accruals. Corporate and other expenses increased to $24 million in the first nine months of 2003 from $21 million in the first nine months of 2002. The increase reflects lower income from employee retirement benefit plans of $7 million and increases in professional services, offset by foreign currency gains of $3 million. Corporate and other expenses in 2002 included $6 million for a special accounting review. The third quarter 2003 income tax benefit includes $1 million in settlements and reductions of prior estimates based on final tax filings in the quarter. ENVIRONMENTAL MATTERS GenCorp's policy is to conduct its businesses with due regard for the preservation and protection of the environment. The Company devotes a significant amount of resources and management attention to environmental matters and actively manages its ongoing processes to comply with extensive environmental laws and regulations. GenCorp is involved in the remediation of environmental conditions that resulted from generally accepted manufacturing and disposal practices in the 1950's and 1960's followed at certain of the Company's plants. In addition, the Company has been designated a Potentially Responsible Party (PRP) with other companies at third party sites undergoing investigation and remediation. The nature of environmental investigation and cleanup activities often makes it difficult to determine the timing and amount of any estimated future costs that may be required for remediation measures. These matters are reviewed and costs associated with the environmental remediation are accrued when it becomes probable that a liability has been incurred and the amount of the Company's liability can be reasonably estimated. The Company's Unaudited Condensed Consolidated Balance Sheet (which is included in Part I, Item 1 of this report) as of August 31, 2003, reflects accrued liabilities of $317 million and amounts recoverable of $216 million from the U.S. government and other third parties for such costs. Pursuant to U.S. government procurement regulations and an agreement with the U.S. government covering environmental contamination at Aerojet's Sacramento and former Azusa, California sites, Aerojet can recover a substantial portion of its environmental remediation costs through the establishment of prices for Aerojet's products and services sold to the U.S. government. The ability of Aerojet to continue recovering these costs from the U.S. government depends on Aerojet's sustained business volume under U.S. government contracts and programs and, to a certain extent, the availability of reimbursements under the agreement with Northrop. The effect of the final resolution of environmental matters and the Company's obligations for environmental remediation and compliance cannot be predicted due to the uncertainty concerning both the amount and timing of future expenditures due to regulatory or technological changes. However, the Company believes, on the basis of presently available information, that the resolution of environmental matters and the Company's obligations for environmental remediation and compliance will not have a material adverse effect on the Company's results of operations, liquidity or financial condition. The Company will continue its efforts to mitigate past and future costs through pursuit of claims for recoveries from insurance coverage and other PRPs and continued investigation of new and more cost effective remediation alternatives and associated technologies. -37- For additional discussion of environmental and related legal matters, see Notes 8(a) and 8(b) in Notes to Unaudited Condensed Consolidated Financial Statements. KEY ACCOUNTING POLICIES AND ESTIMATES The Company prepares its financial statements in accordance with accounting principles generally accepted in the U.S. (GAAP). The preparation of financial statements in accordance with GAAP requires the use of estimates, assumptions, judgments and interpretations that can affect the reported amounts of assets, liabilities, revenues and expenses, the disclosure of contingent assets and liabilities and other supplemental disclosures. Estimates have been prepared on the basis of the most current and best available information, and actual results could differ materially from those estimates. The areas most affected by the Company's accounting policies and estimates are revenue recognition/long-term contracts, goodwill and intangible assets, employee retirement and post retirement benefit plans, litigation, environmental remediation costs and income taxes. These areas are discussed in more detail in the Company's Annual Report on Form 10-K for the year ended November 30, 2002. There have been no significant changes in the Company's key accounting policies during the first nine months of 2003. NEW ACCOUNTING PRONOUNCEMENTS In January 2003, the FASB issued Interpretation No. 46 (FIN 46), Consolidation of Variable Interest Entities, an Interpretation of ARB No. 51. FIN 46 requires certain variable interest entities to be consolidated by the primary beneficiary of the entity if the equity investors in the entity do not have the characteristics of a controlling financial interest or do not have sufficient equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. FIN 46 is effective for all new variable interest entities created or acquired after January 31, 2003. For variable interest entities created or acquired prior to February 1, 2003, the provisions of FIN 46 must be applied for the first interim or annual period beginning after June 15, 2003. The adoption of FIN 46 isdid not expected to have a material effect on the Company’s results of operations, liquidity, or financial condition.

13. Subsequent Events

     In March 2003, one of the Company’s European subsidiaries entered into a $25 million credit facility to provide working capital for its European operations. The credit facility is secured by certain assets of the Company’s European operations.

     In March 2003, the Company announced that it had signed a memorandum of understanding to enter into a joint venture with a real estate management and development firm. The project the proposed joint venture expects to develop is a commercial office complex on a 20-acre parcel of Aerojet’s land.

-22-


Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

     Certain information contained in this report should be considered “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995. These statements present (without limitation) the expectations, beliefs, plans and objectives of management and future financial performance and/or assumptions underlying or judgments concerning matters discussed in this document. The words “believe,” “estimate,” “anticipate,” “project,” and “expect,” and similar expressions are intended to identify forward-looking statements. All forward-looking statements involve certain risks, estimates, assumptions and uncertainties with respect to future sales and activity levels, cash flows, contract performance, the outcome of contingencies including environmental remediation, and anticipated costs of capital.

     Some important risk factors that could cause the Company’s actual results or outcomes to differ from those expressed in its forward-looking statements include, but are not limited to, the following:

Legal and regulatory developments that may have an adverse impact on the Company or its segments. For example:

The Company’s operating results and financial condition could be adversely impacted if the judgment order in the amount of approximately $29 million entered November 21, 2002 against GenCorp inGenCorp Inc. v Olin Corporation(U.S. District Court for the Northern District of Ohio, Eastern Division) is upheld on appeal and reductions to which the Company believes it is entitled are not realized.
Restrictions on real estate development that could delay the Company’s proposed real estate development activities.
A change in toxic tort or asbestos litigation trends which is adverse to the Company.
Changes in international tax laws or currency controls.

Changes in Company-wide or business segment strategies, which may result in changes in the types or mix of business in which the Company is involved or chooses to invest.
Changes in U.S., global or regional economic conditions, which may affect, among other things,

Consumer spending on new vehicles, which could reduce demand for products from the GDX Automotive segment.
Customer funding for the purchase of Aerospace and Defense products which could impact the segment’s business base and, as a result, impact its ability to recover environmental costs.

(list is continued on following page)

-23-


(list is continued from previous page)

Health care spending and demand for the pharmaceutical ingredients produced by the Fine Chemicals segment.
The Company’s ability to successfully complete its real estate strategies.
The funded status and costs related to employee retirement benefit plans.

Changes in U.S. and global financial and equity markets, including market disruptions and significant interest rate fluctuations, which may impede the Company’s access to, or increase the cost of, external financing for its operations and investments.
Increased competitive pressures, both domestically and internationally which may, among other things, affect the performance of the Company’s businesses. For example:

The automotive industry is increasingly outsourcing the production of key vehicle sub-assemblies. Accordingly, industry suppliers, such as the Company’s GDX Automotive segment, will need to demonstrate the ability to be a reliable supplier of integrated components to maintain and expand their market share.
Consolidation in the aerospace and defense industry has been underway for several years. The resulting reduction in the number of prime contractors, increased scale of certain competitors and the reduction in alternative suppliers could negatively affect the Aerospace and Defense segment’s ability to expand.

Labor disputes, which may lead to increased costs or disruption of operations in the Company’s GDX Automotive, Aerospace and Defense, and Fine Chemicals segments.
Changes in product mix, which may affect automotive vehicle preferences and demand for the Company’s GDX Automotive segment’s products.
Technological developments or patent infringement claims which may impact the use of critical technologies in the Company’s GDX Automotive, Aerospace and Defense, and Fine Chemicals segments leading to reduced sales and/or increased costs.
An unexpected adverse result or required cash outlay in the toxic tort cases, environmental proceedings or other litigation, or change in proceedings or investigations pending against the Company.

     This list of factors that may affect future performance and the accuracy of forward-looking statements is illustrative, but by no means exhaustive. Accordingly, all forward-looking statements should be evaluated with the understanding of their inherent uncertainty. Additional risk factors may be described from time to time in the Company’s filings with the U.S. Securities and Exchange Commission. All such risk factors are difficult to predict, contain material uncertainties that may affect actual results, and may be beyond the Company’s control.

-24-


Results of Operating Segments

     The following section pertains to activity included in the Company’s Unaudited Condensed Consolidated Statements of Income, which are contained in Part I, Item 1 of this report, and focuses on the Company’s continuing operations. See Note 11 to the Unaudited Condensed Consolidated Financial Statements for financial results for each of the Company’s operating segments.

GDX Automotive

     GDX Automotive sales for the first quarter of 2003 were $191 million compared to $190 million in the first quarter of 2002. Sales increases from favorable exchange rates of $16 million in the first quarter of 2003 were offset by lower volumes and pricing concessions to major customers.

     Operating profit was $5 million for the first quarter of 2003 compared to $6 million for the first quarter of 2002. Operating profit improvements from favorable exchange rates and cost reductions of $6 million from operating efficiencies in the first quarter of 2003 were offset by reduced income from employee retirement benefit plans of $2 million, pricing concessions and lower sales volumes.

Aerospace and Defense

     Aerospace and Defense sales for the first quarter of 2003 were $63 million, including $12 million from General Dynamics Space Propulsion and Fire Suppression business (GDSS) acquired in October 2002, compared to $54 million reported in the first quarter of 2002. Contributing to the increase in sales were increased volumes on programs for national missile defense and the Boeing Phantom HyFly program. These sales increases were offset by lower sales on various other programs.

     Operating profit of $9 million for the first quarter of 2003 was $7 million lower than the first quarter of 2002, attributable primarily to a $5 million reduction in income from employee retirement benefit plans.

     During the first quarter of 2003, Aerospace and Defense successfully completed the final test firing of the Atlas V solid rocket motor and the successful testing of the Boeing Phantom HyFly dual combustion ramjet test flight engines for the Defense Advanced Research Projects Agency and the Office of Naval Research.

     Contract backlog was $751 million at the end of the first quarter of 2003 compared to $773 million as of November 30, 2002. Funded backlog, which includes only those contracts for which money has been directly authorized by the U.S. Congress, or for which a firm purchase order has been received by a commercial customer, was $363 million at the end of the first quarter of 2003 compared to $416 million as of November 30, 2002. Funding for the Titan program was restructured in the first quarter of 2003, reducing funded backlog by $58 million. Aerojet expects this funding to be incrementally restored in future years.

Fine Chemicals

     Fine Chemicals sales in the first quarter of 2003 totaled $17 million compared to $5 million in the first quarter of 2002. The improvement reflects strong demand for products launched in 2001 and 2002.

-25-


     Fine Chemicals reported an operating profit of $2 million for the first quarter of 2003 compared to a loss of $3 million for the first quarter of 2002. The significant improvement in Fine Chemicals’ operating profit reflects higher sales volumes and reduced labor costs resulting from restructuring initiatives.

Interest and Other Expenses

     Interest expense increased to $5 million in the first quarter of 2003 from $3 million in the first quarter of 2002 due primarily to higher debt resulting from the acquisition of GDSS.

     Corporate and other expenses decreased in the first quarter of 2003 to $6 million compared to $9 million in the first quarter of 2002. Corporate and other expenses in 2003 include $3 million in foreign currency exchange rate gains, increases in professional service fees and compensation costs, and a reduction of $3 million in income from employee retirement benefit plans. Corporate and other expenses in the first quarter of 2002 included $6 million in costs for the accounting review related to the restatement of 1999 and 2000 financial results.

Other Information

Environmental Matters

     GenCorp’s policy is to conduct its businesses with due regard for the preservation and protection of the environment. The Company devotes a significant amount of resources and management attention to environmental matters and actively manages its ongoing processes to comply with extensive environmental laws and regulations. The Company is involved in the remediation of environmental conditions that resulted from generally accepted manufacturing and disposal practices in the 1950’s and 1960’s followed at certain GenCorp plants. In addition, the Company has been designated a PRP with other companies at third party sites undergoing investigation and remediation.

     The nature of environmental investigation and cleanup activities often makes it difficult to determine the timing and amount of any estimated future costs that may be required for remediation measures. The Company reviews these matters and accrues for costs associated with the environmental remediation when it becomes probable that a liability has been incurred and the amount of the Company’s liability can be reasonably estimated. The Company’s Unaudited Condensed Consolidated Balance Sheet (which are included in Part I, Item 1 of this report) as of February 28, 2003 reflects accruals of $336 million and amounts recoverable of $229 million from the U.S. Government and other third parties for such costs. Pursuant to U.S. Government procurement regulations and a Global Settlement covering environmental contamination at the Company’s Sacramento and former Azusa, California sites, Aerojet can recover a substantial portion of its environmental costs for its Aerospace and Defense segment through the establishment of prices for the Company’s products and services sold to the U.S. Government. The ability of Aerojet to continue recovering these costs from the U.S. Government depends on Aerojet’s sustained business volume under U.S. Government contracts and programs and is subject to the limitations of the Northrop Grumman agreement.

     The effect of the final resolution of environmental matters and Aerojet’s obligations for environmental remediation and compliance cannot be predicted due to the uncertainty concerning both the amount and timing of future expenditures due to regulatory or technological changes. However, management believes, on the basis of presently available information, that the resolution of

-26-


environmental matters and the Company’s obligations for environmental remediation and compliance will not have a material adverse effect on the Company’sCompany's results of operations, liquidity, or financial condition. The Company will continue its efforts to mitigate past and future costs through pursuit of claims for recoveries from insurance coverage and other PRPs and continued investigation of new and more cost effective remediation alternatives and associated technologies.

     For additional discussion of environmental and related legal matters, see Note 7(b) in Notes to Unaudited Condensed Consolidated Financial Statements.

New Accounting Pronouncements

In JanuaryMay 2003, the FASB issued Statement of Financial Accounting Standards No. 149 (SFAS 149), Amendment of Statement 133 on Derivative Instruments and Hedging Activities. SFAS 149 is intended to result in more consistent reporting of contracts as either freestanding derivative instruments subject to Statement 133 in its entirely, or as hybrid instruments with debt host contracts and embedded derivative features. SFAS 149 is effective for contracts entered into or modified after June 30, 2003. The adoption of SFAS 49 did not have a material effect on the Company's results of operations, liquidity, or financial condition. In May 2003, the FASB Interpretationissued Statement of Financial Accounting Standards No. 46 (FIN 46)150 (SFAS 150),Consolidation Accounting for Certain Financial Instruments with Characteristics of Variable Interest Entities, an Interpretation of ARB No. 51. FIN 46Both Liabilities and Equity. SFAS 150 requires certain variable interest entitiesfinancial instruments that embody obligations of the issuer and have characteristics of both liabilities and equity to be consolidated by the primary beneficiaryclassified as liabilities. Many of the entity if thethese instruments previously were classified as equity investorsor temporary equity and as such, SFAS 150 represents a significant change in practice in the entity do not have the characteristicsaccounting for a number of a controlling financial interest or do not have sufficientmandatorily redeemable equity at risk for the entity to finance its activities without additional subordinated financial support from other parties. FIN 46instruments and certain equity derivatives that frequently are used in connection with share repurchase programs. SFAS 150 is effective for all new variable interest entitiesfinancial instruments created or acquiredmodified after JanuaryMay 31, 2003. For variable interest entities created or acquired prior2003, and to February 1, 2003,other instruments at the provisionsbeginning of FIN 46 must be applied for the first interim or annual period -38- beginning after June 15, 2003. The adoption of FIN 46 isSFAS 150 did not expected to have a material effect on the Company’sCompany's results of operations, liquidity, or financial condition.

Liquidity and Capital Resources

LIQUIDITY AND CAPITAL RESOURCES The Company broadly defines liquidity as its ability to generate sufficient operating cash flows, as well as its ability to obtain debt and equity financing and to convert to cash those assets that are no longer required to meet its strategic and financial objectives. Changes in net cash provided by operating activities generally reflect earnings plus depreciation and amortization and other non-cash charges and the effect of changes in working capital. Changes in working capital generally are the result of timing differences between the collection of customer receivables and payment for materials and operating expenses.

expenses Net cash used inprovided by (used in) operating activities

     As Operating activities provided net cash of February 28, 2003, the Company’s cash and cash equivalents totaled $45$7 million and the ratio of current assets to current liabilities, or current ratio, was 1.10. As of November 30, 2002, the Company’s cash and cash equivalents were $48 million and the current ratio was 1.03.

     Net cash used in operating activities for the first threenine months of 2003 was $13compared to a $40 million compared with $3 millionuse of cash in the first threenine months of 2002. The increase in operating cash flow in 2003 reflects improved operating results for the Aerospace and Defense and Fine Chemical segments (after adjusting for the non-cash impact of employee retirement benefit plans) offset in part by reduced profits for the GDX Automotive segment. Operating cash flows in 2003 also reflect a reduction in working capital usage, primarily in the Aerospace and Defense segment, as compared to the same period in 2002. Net cash used in operating activities for the first threenine months of 2003fiscal 2002 was negatively affected by working capital requirements.

-27-


Net cash used in investing activities

requirements, including needs for Aerojet's fixed-price production contracts such as the Atlas V program. Net cash used in investing activities The Company used $111 million in cash for investing activities for the first threenine months of 2003 was $2compared to $35 million versus $14 millionused for the comparable period in 2002. Included in cash used in investing activities in 2003 is $95 million of restricted cash from the net proceeds of the senior subordinated notes issued in August 2003. Capital expenditures totaled $9$36 million for the first threenine months of 2003 and $6$31 million for the first threenine months of 2002. The Company’sCompany's capital expenditures directly support the Company’sCompany's contract and customer requirements and are primarily made for asset replacement and capacity expansion, cost reduction initiatives and safety and productivity improvements. Investing activities in the first quarternine months of 2003 included a cash inflow of $7 million from the sale of GDX Automotive assets and operations in Viersen, Germany.Germany and $13 million from the sale of a building complex (after transaction costs and tenant improvement obligations). Investing activities for the first quarternine months of 2002 included a net cash outflow of approximately $8 million related to the Company’sCompany's reacquisition of the minority interest in AFC.

Net cash provided by financing activities

Net cash provided by financing activities for the first threenine months of 2003 was $9$113 million compared with $26$66 million for the first threenine months of 2002. Cash flow related tofrom financing activities in both periods relaterelates primarily to activities involving the Company’s Restated Credit Facility,Company's borrowings, net of repayments. The Company paid dividends of $1$4 million in both periods presented. On February 28, 2002August 11, 2003, GenCorp sold $150 million aggregate principal amount of its 9-1/2% the senior subordinated notes due August 2013. Issuance of the senior subordinated notes generated -39- net proceeds of $145 million. The Company used approximately $50 million of the net proceeds to repay the then existing balance of the revolving credit facility. Amounts repaid under the revolving credit facility may be reborrowed. The remaining net proceeds of $95 million are held in a restricted cash account to be used for the ARC Propulsion acquisition. Under an amendment and waiver to the senior credit facility, if the Company amendeddoes not complete the ARC Propulsion acquisition by December 31, 2003, GenCorp will be required to use the balance of the net proceeds to repay in full outstanding indebtedness under term loan A, plus accrued and unpaid interest, with the remainder to be used to repay outstanding indebtedness under term loan B, plus accrued and unpaid interest, subject to modification in accordance with the terms of the amendment and waiver. Once repaid, term loan A and term loan B indebtedness may not be reborrowed. In April 2002, GenCorp sold $150 million aggregate principal amount of its Credit Facility to provide an additionalconvertible subordinated notes due 2007 in a private placement. The net proceeds of the offering were approximately $144 million. The Company used approximately $25 million of the net proceeds to repay in full term loan (Term Loan C). The $25 million was repaid on April 5, 2002. The CompanyC and does not have the ability to re-borrowreborrow these funds.

Outlook

The Company also used approximately $119 million to repay outstanding debt under the revolving credit facility. Amounts repaid against the outstanding debt under the revolving credit facility may be reborrowed at any time or from time to time and may be used for any purpose, subject to the limits contained in the senior credit facility. Liquidity At August 31, 2003 and November 30, 2002, unrestricted cash and cash equivalents totaled $61 million and $48 million, respectively, and availability under the Company's credit facilities totaled $97 million and $75 million, respectively. Restricted cash of $95 million at August 31, 2003, must be used either to fund the acquisition of ARC Propulsion or, in the event the acquisition does not close by December 31, 2003, to repay term loans. The Company currently believes that its existing cash and cash equivalents, forecasted operating cash flows for the next twelve months,from operations and asset sales and borrowings available under its credit facilities will provide sufficient funds to meet its operating plan for the next twelve months. ThisThe operating plan for this period provides for full operation of the Company’sCompany's business, interest and principal payments on the Company’sCompany's debt and anticipated dividend payments.

     The Company is pursuing its appeal of a partial judgment in the case ofGenCorp Inc. v. Olin Corporation, rather than seek further review of an Order of the United States Sixth Circuit Court of Appeals issued on February 13, 2003. In order to move forward with this appeal, the Company posted a bond covering the judgment and related interest in the amount of $30 million. While the bond reduces liquidity, the Company currently believes that its existing cash and cash equivalents, forecasted operating cash flows and borrowings available under its credit facilities will provide sufficient funds to meet its operating plan for the next twelve months. See Note 7(a) in Notes to Unaudited Condensed Consolidated Financial Statements.

     The Company intends to continue to access capital markets to raise debt or equity financing to fund strategic acquisitions, as well as to provide additional liquidity for its operational requirements for the next twelve months. The timing, terms, size and pricing of any cash financing will depend on investor interest and market conditions, and there can be no assurance that the Company will be able to obtain any such financing.

-28-


If the Company experiences adverse economic developments and is not able to raise debt or equity financing in the capital markets or to obtain bank borrowings, the Company believes that it can generate additional funds to meet its liquidity requirements for the next twelve months by reducing working capital requirements, deferring capital expenditures, implementing cost reduction initiatives in addition to those already included in the Company’sCompany's operating plan, selling assets, or through a combination of these means.

Major factors that could adversely impact the Company’sCompany's forecasted operating cash and its financial condition are described in “Forward-Looking Statements” above."Forward-Looking Statements" and "Risk Factors" below. In addition, the Company’sCompany's liquidity and financial condition will continue to be affected by changes in prevailing interest rates on the portion of debt that bears interest at variable interest rates.

Item -40- FORWARD-LOOKING STATEMENTS Certain information contained in this report should be considered "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. These statements present (without limitation) the expectations, beliefs, plans and objectives of management and future financial performance and/or assumptions underlying or judgments concerning matters discussed in this document. The words "believe," "estimate," "anticipate," "project," and "expect," and similar expressions are intended to identify forward-looking statements. Forward-looking statements involve certain risks, estimates, assumptions and uncertainties with respect to future sales and activity levels, cash flows, contract performance, the outcome of contingencies including environmental remediation, and anticipated costs of capital some of which are described in "Risk Factors." RISK FACTORS A variety of factors could cause actual results or outcomes to differ materially from those expected by the Company and expressed in the Company's forward-looking statements. Some important risk factors that could cause actual results or outcomes to differ from those expressed in the forward-looking statements include, but are not limited to, the following: - Legal and regulatory developments that may have an adverse impact on the Company or its segments. For example: 1) the judgment order in the amount of approximately $29 million entered November 21, 2002 against GenCorp in GenCorp Inc. v Olin Corporation (U.S. District Court for the Northern District of Ohio, Eastern Division), if it is upheld on appeal and the reductions to which the Company believes it is entitled are not realized; 2) restrictions on real estate development that could delay the Company's proposed real estate development activities; 3) a change in toxic tort or asbestos litigation trends that is adverse to the Company; and 4) changes in international tax laws or currency controls. - Changes in Company-wide or business segment strategies, which may result in changes in the types or mix of business in which the Company is involved or chooses to invest. - Changes in U.S., global or regional economic conditions, which may affect, among other things, 1) consumer spending on new vehicles which could reduce demand for products from the GDX Automotive segment, 2) customer funding for the purchase of Aerospace and Defense products which may impact the segment's business base and, as a result, impact its ability to recover environmental costs, 3) health care spending and demand for the pharmaceutical ingredients produced by Fine Chemicals, 4) the Company's ability to successfully complete its real estate activities, and 5) the funded status and costs related to employee retirement benefit plans. - Changes in U.S. and global financial markets, including market disruptions, and significant currency or interest rate fluctuations, which may impede the Company's access to, or increase the cost of, external financing for its operations and investments and/or materially affect results of operations and cash flows. - Risks associated with the Company's Aerospace and Defense segment's being a defense contractor including: 1) the right of the U.S. government to terminate any contract for convenience; 2) modification or termination of U.S. government contracts due to lack of congressional funding; and 3) the lack of assurance that bids for new programs will be -41- successful, contract options will be exercised or follow-on contracts will be awarded in light of the competitive bidding atmosphere under which most contracts are awarded. - Increased competitive pressures both domestically and internationally which may, among other things, affect the performance of the Company's businesses. For example, the automotive industry is increasingly outsourcing the production of key vehicle sub-assemblies. Accordingly, industry suppliers, such as the Company's GDX Automotive segment, will need to demonstrate the ability to be a reliable supplier of integrated components to maintain and expand their market share. - Labor disputes, which may lead to increased costs or disruption of operations in the Company's GDX Automotive, Aerospace and Defense and Fine Chemicals segments. - Changes in product mix, which may affect automotive vehicle preferences and demand for the Company's GDX Automotive segment's products. - Technological developments or patent infringement claims which may impact the use of critical technologies in the Company's GDX Automotive, Aerospace and Defense and Fine Chemicals segments leading to reduced sales and/or increased costs. - An unexpected adverse result or required cash outlay in the toxic tort cases, environmental proceedings or other litigation, or change in proceedings or investigations pending against the Company. These and other factors are described in more detail in the Company's Annual Report on Form 10-K for the year ended November 30, 2002 and its subsequent filings with the Securities and Exchange Commission. Additional risks may be described from time-to-time in future filings with the U.S. Securities and Exchange Commission. All such risk factors are difficult to predict, contain material uncertainties that may affect actual results, and may be beyond the Company's control. ITEM 3. Quantitative and Qualitative Disclosures About Market Risk

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK There have been no material changes to the Company’sCompany's disclosures related to certain market risks as reported under Part II, Item 7A, “Quantitative"Quantitative and Qualitative Disclosures About Market Risk," in the Annual Report of GenCorp to the U.S. Securities and Exchange Commission on Form 10-K for the year ended November 30, 2002, except as noted below.

Interest Rate Risk

INTEREST RATE RISK The Company uses interest rate swaps and a combination of fixed and variable rate debt to reduce its exposures to interest rate risk. As required under the Restated Credit Facility, theThe Company entered into interest rate swap agreements, effective January 10, 2003, on $100 million of its variable-rate debt (see Note 67 in Notes to Unaudited Condensed Consolidated Financial Statements). The remaining variable-rate debt under the Company’s Restated Credit FacilityCompany's bank credit agreements of approximately $141$92 million is subject to fluctuations in market interest rates. A one-percentage point increase in interest rates on the unhedged variable-rate debt as of February 28,August 31, 2003, would decrease annual pretax income by $1 million.

Item -42- FOREIGN CURRENCY EXCHANGE RISK The Company periodically uses foreign currency forward contracts to reduce its exposure to exchange rate fluctuations on intercompany loans denominated in foreign currencies. In the second quarter of 2003, the Company entered into three foreign currency forward contracts. Two of the contracts totaling 15 million Euro matured in April. As of August 31, 2003, the Company has one forward contract outstanding totaling 7 million Euro which matures November 28, 2003. Forward contracts are marked-to-market each period and unrealized gains or losses are included in other income and expense. The unrealized loss on the outstanding forward contract was not material to the Company's consolidated financial statements. The remaining foreign currency denominated debt is not material to the Company's consolidated financial statements. ITEM 4. ControlsCONTROLS AND PROCEDURES (a) Evaluation of disclosure controls and Procedures

(a)Evaluation of disclosure controls and procedures. The Company’s principal executive officer and its principal financial officer, based on their evaluation of the Company’s disclosure controls and procedures (as defined in Exchange Act Rules 13a –14 (c) as of a date within 90 days prior to the filing of this Quarterly Report on Form 10Q, have concluded that the Company’s disclosure controls and procedures are adequate and effective for the purposes set forth in the definition in Exchange Act rules.
(b)Changes in internal controls. There were no significant changes in the Company’s internal controls or in other factors that could significantly affect the Company’s internal controls subsequent to the date of their evaluation.

-29-


procedures. The Company's principal executive officer and its principal financial and accounting officer, based on their evaluation of the Company's disclosure controls and procedures, as defined in Exchange Act Rules 13a - 14(c), as of August 31, 2003, have concluded that the Company's disclosure controls and procedures are adequate and effective for the purposes set forth in the definition in Exchange Act rules. (b) Changes in internal controls. There were no significant changes in the Company's internal controls or in other factors that could significantly affect the Company's internal controls subsequent to the date of their evaluation. PART II - OTHER INFORMATION

Item ITEM 1. Legal Proceedings

LEGAL PROCEEDINGS Except as disclosed in Note 7(a)8(a), Note 8(b) and Note 7(b)15 in Part I and incorporated herein by reference, there have been no significantmaterial developments in the pending legal proceedings as previously reported in the Annual Report of GenCorp Inc. to the SEC on Form 10-K for the year ended November 30, 2002.2002 and subsequent periodic reports filed with the SEC. Reference is made to Item 3, Legal Proceedings in ourthe Company's Annual Report on Form 10-K for the year ended November 30, 2002.

2002 and to Part II, Item 4. Submission1, Legal Proceedings in our Quarterly Report on Form 10-Q for the quarters ended May 31, 2003 and February 28, 2003. ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K A) Exhibits No. Description --- ----------- 2.1 First Amendment to Purchase Agreement, dated August 29, 2003, between Aerojet-General Corporation and Atlantic Research Corporation (filed as Exhibit 2.2 to GenCorp's Registration Statement on Form S-4 (File No. 333-109518) and incorporated herein by reference) 2.2 Second Amendment to Purchase Agreement, dated September 30, 2002, between Aerojet-General Corporation and Atlantic Research Corporation. -43- 3.1 Amended Articles of Matters to a Vote of Security Holders

     At the Company’s Annual Meeting of Shareholders on March 26, 2003, holdersIncorporation of GenCorp Common Stock elected J. Gary Cooper, James M. Osterhoff,Inc. filed with the Secretary of State of Ohio on August 7, 2003 (filed as Exhibit 3.1 to GenCorp's Registration Statement on Form S-4 (File No. 333-109518) and Steven G. Rothmeierincorporated herein by reference) 4.1 Indenture, dated as directorsof August 11, 2003, between GenCorp Inc., the Guarantors named therein and The Bank of New York, as trustee (filed as Exhibit 4.1 to serve GenCorp's Registration Statement on Form S-4 (File No. 333-109518) and incorporated herein by reference) 4.2 Registration Rights Agreement, dated as of August 11, 2003, among GenCorp Inc., the Guarantors named therein and the Initial Purchasers named therein (filed as Exhibit 4.2 to GenCorp's Registration Statement on Form S-4 (File No. 333-109518) and incorporated herein by reference) 4.3 Form of Initial Notes (included in Exhibit 4.1) 4.4 Form of Exchange Notes (including in Exhibit 4.1) 10.1 Amendment No. 1 to Amended and Restated Credit Agreement and Limited Waiver and consent, dated July 29, 2003, among GenCorp Inc., Deutsche Bank Trust Company Americas (f/k/a three-year term expiring in 2006. Previously, James J. Didion, William K. HallBankers Trust Company), for itself, as a Lender, and Dr. Sheila E. Widnall were elected as directorsAdministrative Agent for the Lenders, and Terry L. Hall was appointedthe other Lenders signatory thereto (Filed as Exhibit 10.1 to serve three-year terms that continue until March 2005GenCorp's Registration statement on Form S-4 (File No. 333-109518) and J. Robert Anderson, Irving Gutin,incorporated herein by reference.) 10.2 Amendment No. 2 to Amended and Robert A. Wolfe were electedRestated Credit dated August 25, 2003, among GenCorp Inc., Deutsche Bank Trust Company Americas (f/k/a Bankers Trust Company), for itself, as directorsa Lender, and as Administrative Agent for the Lenders, and the other Lenders signatory thereto (Filed as Exhibit 10.2 to serve three-year terms that continue until March 2004.

     Shareholders also ratifiedGenCorp's Registration statement on Form S-4 (File No. 333-109518) and incorporated herein by reference.) 31.1 Certification of Chief Executive Officer required by Rule 13a-14(a) under the BoardSecurities Exchange Act of Directors’ appointment1934, as amended. 31.2 Certification of Ernst & Young LLPChief Financial Officer required by Rule 13a-14(a) under the Securities Exchange Act of 1934, as the Company’s independent auditors for 2003.

     Following is the final resultamended. 32.1 Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the votes cast:

A)Election of Directors:

             
Broker
Nominee For Withheld NonvotesTotal

 
 
 
 
J. Gary Cooper  37,833,347   1,470,861   39,304,208 
James M. Osterhoff  37,811,376   1,492,832   39,304,208 
Steven G. Rothmeier  37,860,511   1,443,697   39,304,208 

Sarbanes-Oxley Act of 2002. B)Ratification of the Board of Directors’ appointment of Ernst & Young LLP as independent auditors:

      For: 37,953,873Against: 1,158,331Abstain: 192,004Broker Nonvotes: -0-

-30-


Item 6. Exhibits and Reports on Form 8-K

A)Exhibits

No.Description
10.1Form of Employee Restricted Stock Option Agreement between the Company and Certain Officers providing for vesting based on achieving an Earnings Per Share Target which is to be adjusted annually.

B)Reports on Form 8-K

          On March 27, 2003, the Company filed a Form 8-K incorporating: 1) its press release dated March 26, 2003 in which the Company announced that its real estate operation has completed a Memorandum of Understanding to enter into a joint venture with Panattoni Development Company; and 2) its press release dated March 26, 2003 in which the Company reported net income for the first quarter of 2003 of $3 million ($.07 per diluted share) unchanged from the first quarter of 2002.

          On March 11, 2003, the Company filed a Form 8-K incorporating its press release dated March 10, 2003, in which the Company reported it is pursuing its appeal of a partial judgment in the case ofGenCorp Inc. v. Olin Corporation.

          On January 23, 2003, the Company filed a Form 8-K incorporating its press release of the same date, in which the Company reported net income for 2002 of $30 million ($0.69 per share) compared to net income of $128 million ($3.00 per share) for 2001.

          On December 6, 2002, the Company filed a Form 8-K incorporating its press release dated December 4, 2002, in which the Company affirmed its earnings guidance for 2002.

-31-


Signatures

On July 28, 2003, the Company filed an 8-K under Item 5 thereof with respect to its press release dated July 24, 2003 in which the Company announced that its Aerojet subsidiary is selling a 96,000 square foot office complex on approximately 11 acres in Sacramento County for $14.9 million and its press release dated July 25, 2003 in which the Company announced that it is planning to issue $175 million senior subordinated notes due 2013 in a private placement to institutional investors. -44- On August 8, 2003, the Company filed an 8-K under Item 5 thereof with respect to its press release dated August 6, 2003 in which the Company announced that it has agreed to sell $150 million aggregate principal amount of senior subordinated notes due 2013 in a private placement to institutional investors. On September 8, 2003, the Company filed an 8-K under Item 9 and Item 12 thereof with respect to its press release dated September 4, 2003 revising previously issued earnings guidance for the third quarter and fiscal year 2003 and announcing several personnel actions that have been taken or will be taken at the GDX executive level. On October 6, 2003, the Company filed a Form 8-K under Item 9 and Item 12 thereof with respect to its press release dated October 6, 2003 in which the Company announced a third quarter of 2003 loss of $2 million, or $0.05 per share, compared to $10 million or $0.19 per share for the third quarter of 2002. On October 9, 2003, the Company filed a Form 8-K under Item 5 thereof with respect to its press release dated October 6, 2003 announcing the resignation of Michael Bryant from his positions as President of GDX Automotive and Vice President of GenCorp Inc. -45- SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

GenCorp Inc.
Date: April 8, 2003By:/s/ Yasmin R. Seyal

Yasmin R. Seyal
Chief Financial Officer (Principal Financial
and Accounting Officer)
Date: April 8, 2003By:/s/ Terry L. Hall

Terry L. Hall
President and Chief Executive Officer/Director

-32-


CERTIFICATIONS

I, GenCorp Inc. Date: October 15, 2003 By: /s/ Terry L. Hall certify that:

1.I have reviewed this quarterly report on Form 10-Q of GenCorp Inc.;
2.Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
3.Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

a)designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b)evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and
c)presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

5.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a)all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and
b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

6.The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Date: April 8, 2003
/s/ Terry L. Hall

Terry L. Hall
President and Chief Executive Officer

-33-


CERTIFICATIONS

I,----------------------------------- Terry L. Hall President and Chief Executive Officer Date: October 15, 2003 By: /s/ Yasmin R. Seyal certify that:

1.I have reviewed this quarterly report on Form 10-Q of GenCorp Inc.;
2.Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
3.Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
4.The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:

a)designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b)evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and
c)presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

5.The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a)all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and
b)any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

6.The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

Date: April 8, 2003
/s/ Yasmin R. Seyal

Yasmin R. Seyal
----------------------------------- Yasmin R. Seyal Senior Vice President, and
Chief Financial Officer

-34-


CERTIFICATIONS
Pursuant to 18 United States Code § 1350

The undersigned hereby certifies that to his knowledge the quarterly report of GenCorp Inc. (the “Company”) filed with the Securities and Exchange Commission on the date hereof fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Terry L. Hall

Name:Terry L. Hall
Title:President and Chief Executive Officer
Date:April 8, 2003

The undersigned hereby certifies that to her knowledge the quarterly report of GenCorp Inc. (the “Company”) filed with the Securities and Exchange Commission on the date hereof fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Yasmin R. Seyal

Name:Yasmin R. Seyal
Title:Senior Vice President and
Chief Financial Officer
Date:April 8, 2003

-35-

Principal Accounting Officer -46-